Systemic lupus erythematosus

M13_SLE

systemic lupus erythematosus: An autoimmune multi-organ disease typically associated with vasculopathy and autoantibody production. Most patients have antinuclear antibodies (ANA). The presence of anti-dsDNA or anti-Smith antibodies are highly-specific.

Suggest a new description

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	519972
1. Apply sex-specific rule None	519972
2. Check conditions None	519972
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — M32 Hospital discharge: ICD-9 — 7100 Hospital discharge: ICD-8 — 7431 Cause of death: ICD-10 — M32 Cause of death: ICD-9 — 7100 Cause of death: ICD-8 — 7431 2 out of 7 registries used, show all original rules.	1392
4. Check minimum number of events None	1392
5. Include endpoints None	1392
6. Filter based on genotype QC (FinnGen only)	1340

Control definitions (FinnGen only)

Control exclude: M13_SYSTCONNECT

Extra metadata

Level in the ICD hierarchy: 3
First used in FinnGen datafreeze: DF2
Parent code in ICD-10: M30-M36
Name in latin: Lupus erythematosus disseminatus (LED)

NAME	M13_SLE
CONTROL_EXCLUDE	M13_SYSTCONNECT
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	M32
HD_ICD_9	7100
HD_ICD_8	7431
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	M32
COD_ICD_9	7100
COD_ICD_8	7431
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Systemic lupus erythematosus based on the number of shared cases.

Similar with more cases:

Similar with less cases:

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	1340	1104	236
Unadjusted period prevalence (%)	0.34	0.39	0.11
Median age at first event (years)	47.56	46.11	54.36

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
1392: Matched controls
13920

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

M35.9

ICD-10 Finland

Systemic involvement of connective tissue, unspecified

1243.8

314.0

295

P01BA02

ATC

hydroxychloroquine; oral

66.9

307.7

1024

556

M32.9

ICD-10 Finland

Systemic lupus erythematosus, unspecified

9111.4

307.7

1146

202

Kela drug reimbursment

Connective tissue diseases, rheumatoid arthritis and comparable disease

38.0

307.7

953

753

L04AA06

ATC

mycophenolic acid; systemic

61.0

307.7

259

M35.0

ICD-10 Finland

Sicca syndrome [Sjögren]

145.0

307.7

220

M32.8

ICD-10 Finland

Other forms of systemic lupus erythematosus

+∞

307.7

327

L93.0

ICD-10 Finland

Discoid lupus erythematosus

109.4

307.7

181

L04AX01

ATC

azathioprine; systemic

25.5

307.7

402

218

NK4XE

NOMESCO Finland

Joint ultrasound examination not elsewhere classified

13.0

307.7

434

470

L04AX03

ATC

methotrexate; systemic

8.8

288.4

446

705

M32.0

ICD-10 Finland

Drug-induced systemic lupus erythematosus

+∞

262.0

243

M32.1

ICD-10 Finland

Systemic lupus erythematosus with organ or system involvement

+∞

251.9

234

H02AB06

ATC

prednisolone; systemic

7.0

228.2

1090

4754

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

5.5

216.8

884

3332

NK6QA

NOMESCO Finland

Measurement of bone density from two or more locations with X-ray

7.9

194.0

304

475

7100A

ICD-9 Finland

Diffuse diseases of connective tissue, Systemic lupus erythematosus

+∞

193.3

181

H02AB07

ATC

prednisone; oral

5.7

187.2

453

1085

M32

ICD-10 Finland

Systemic lupus erythematosus

+∞

180.2

169

TNX10

NOMESCO Finland

Arthrocentesis, unspecified region, unspecified region

7.3

173.4

289

480

M05BA04

ATC

alendronic acid; oral

6.6

170.0

320

602

N08.5*M32.1

ICD-10 Finland

Glomerular disorders in systemic lupus erythematosus

+∞

155.2

146

TQX10

NOMESCO Finland

Biopsy of skin and subcutaneous tissue

6.0

154.1

318

650

L01BA01

ATC

methotrexate; systemic

9.5

141.9

179

213

L88

ICPC

Rheumatoid/seropositive arthritis

8.9

137.4

183

233

GD1AA

NOMESCO Finland

Thorax X-ray examination

3.7

123.8

859

4213

XX9XE

NOMESCO Finland

Other ultrasound examination

27.5

121.0

KA3AT

NOMESCO Finland

Biopsy of kidney with ultrasound guidance

20.3

119.8

M35.1

ICD-10 Finland

Other overlap syndromes

+∞

114.2

108

L04AD01

ATC

ciclosporin; systemic

14.7

113.6

104

C08CA05

ATC

nifedipine; systemic

6.4

105.3

190

336

L04AA01

ATC

[U] ciclosporin

17.7

102.9

73410

ICD-8 Finland

Diffuse diseases of connective tissue, Systemic lupus erythematosus

1017.4

98.3

R50.9

ICD-10 Finland

Fever, unspecified

3.9

96.8

360

1150

ND2AA

NOMESCO Finland

Hand and fingers X-ray examination

4.4

86.8

249

655

M05.8

ICD-10 Finland

Other seropositive rheumatoid arthritis

5.5

85.3

180

367

H02AB04

ATC

methylprednisolone; systemic

3.5

79.9

342

1185

D68.8

ICD-10 Finland

Other specified coagulation defects

13.4

77.3

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

3.7

76.8

293

940

P01BA01

ATC

chloroquine; systemic

25.7

74.2

ZX120

NOMESCO Finland

Intravenous

4.0

72.5

238

687

C03CA01

ATC

furosemide; systemic

2.9

70.5

481

2164

ND2DA

NOMESCO Finland

Bilateral hand X-ray examination

9.1

69.9

103

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

2.7

68.4

542

2629

GD1DD

NOMESCO Finland

High resolution CT examination of lungs

5.4

62.5

130

260

J18.9

ICD-10 Finland

Pneumonia, unspecified

2.8

59.7

411

1835

M35.3

ICD-10 Finland

Polymyalgia rheumatica

8.8

56.2

NH3AA

NOMESCO Finland

Foot and toes X-ray examination

3.5

56.1

214

678

A49.9

ICD-10 Finland

Bacterial infection, unspecified

3.5

54.8

210

667

TPH04

NOMESCO Finland

Cathetrisation of vein

2.7

54.0

397

1820

J01MA12

ATC

levofloxacin; systemic

2.8

53.7

338

1431

Z01.0

ICD-10 Finland

Examination of eyes and vision

2.8

53.4

351

1519

FM1AE

NOMESCO Finland

Standard cardiac ultrasound examination

2.8

51.8

310

1276

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

3.4

51.4

213

710

A02BC02

ATC

pantoprazole; systemic

2.6

51.3

1064

7695

NF1AE

NOMESCO Finland

Hip joint ultrasound examination

6.7

50.7

128

123

Kela drug reimbursment

Chronic disorders of vitamin D metabolism

9.4

48.9

G05.8*M32.1

ICD-10 Finland

Encephalitis in systemic lupus erythematosus

+∞

48.2

I15.1

ICD-10 Finland

Hypertension secondary to other renal disorders

12.4

48.1

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

2.3

47.8

732

4587

NH3DA

NOMESCO Finland

Bilateral foot X-ray examination

6.7

47.3

121

D69.3

ICD-10 Finland

Idiopathic thrombocytopenic purpura

14.9

46.9

138

Kela drug reimbursment

Severe anaemia associated with chronic renal failure

8.8

46.2

M13.9

ICD-10 Finland

Arthritis, unspecified

3.6

46.1

169

519

E0000UV, ,

ATC

2.2

45.6

701

4372

H26.3

ICD-10 Finland

Drug-induced cataract

15.2

45.2

DM1AA

NOMESCO Finland

Paranasal sinuses X-ray examination without contrast

5.2

44.9

192

D07AB08

ATC

desonide; topical

3.0

44.8

231

872

N18.0

ICD-10 Finland

End-stage renal disease

17.3

44.6

H04.10

ICD-10 Finland

Dry eye syndrome

2.8

44.1

253

1012

I73.0

ICD-10 Finland

Raynaud syndrome

8.2

43.7

B01AA03

ATC

warfarin; systemic

2.8

43.5

265

1093

Z94.0

ICD-10 Finland

Kidney transplant status

14.8

43.5

L93.1

ICD-10 Finland

Subacute cutaneous lupus erythematosus

227.0

43.2

SBA10

NOMESCO Finland

Measurement of salivary flow rate

11.9

43.1

N08.5

ICD-10 Finland

Glomerular disorders in systemic connective tissue disorders

+∞

42.9

1XC02, ,

NOMESCO Finland

15.0

42.6

J01FF01

ATC

clindamycin; systemic

2.3

42.0

466

2528

N18.9

ICD-10 Finland

Chronic kidney disease, unspecified

4.6

42.0

103

236

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

2.4

41.8

371

1829

D69.6

ICD-10 Finland

Thrombocytopenia, unspecified

7.9

41.0

N02AX02

ATC

tramadol; systemic, rectal

2.1

38.9

654

4144

KA1AE

NOMESCO Finland

Kidney ultrasound examination

7.0

38.8

B07.9

ICD-10 Finland

Verruca simplex

4.7

38.1

208

L04AA13

ATC

[U] leflunomide

5.6

37.7

136

R4120

NOMESCO Finland

Occupational therapy

3.5

37.6

142

443

M79.0

ICD-10 Finland

Rheumatism, unspecified

4.5

37.6

227

M05BB03

ATC

alendronic acid and colecalciferol; oral

6.0

37.5

119

Z49.1

ICD-10 Finland

Extracorporeal dialysis

11.4

37.2

L30.9

ICD-10 Finland

Dermatitis, unspecified

2.3

35.9

355

1819

M05BA07

ATC

risedronic acid; oral

4.7

35.6

186

J01EE01

ATC

sulfamethoxazole and trimethoprim; systemic

3.6

35.0

121

356

J99.1*M32.1

ICD-10 Finland

Respiratory disorders in systemic: lupus erythematosus

+∞

34.5

O99.89

ICD-10 Finland

Other specified diseases and conditions complicating pregnancy, childbirth and the puerperium

5.6

34.4

122

M34.9

ICD-10 Finland

Systemic sclerosis, unspecified

345.3

34.1

127

Kela drug reimbursment

Transplant complication

8.7

33.6

G73.7*M32.1

ICD-10 Finland

Myopathy in systemic lupus erythematosus

+∞

33.5

KH1AE

NOMESCO Finland

Urinary tract ultrasound examination

3.8

33.4

107

299

D07AC01

ATC

betamethasone; topical

2.0

33.4

563

3518

TK800

NOMESCO Finland

Hemodialysis

7.6

32.8

A11CC03

ATC

alfacalcidol; systemic

6.1

32.6

J01MA02

ATC

ciprofloxacin; systemic

2.0

32.5

566

3567

O99.1

ICD-10 Finland

Other diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism complicating pregnancy, childbirth and the puerperium

12.6

32.5

J84.8

ICD-10 Finland

Other specified interstitial pulmonary diseases

12.6

32.5

J90

ICD-10 Finland

Pleural effusion, not elsewhere classified

5.1

32.4

140

Z01.8

ICD-10 Finland

Other specified special examinations

2.1

32.2

382

2092

M06.9

ICD-10 Finland

Rheumatoid arthritis, unspecified

4.5

31.9

186

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

2.6

31.8

207

874

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

2.8

31.5

180

712

ZY020

NOMESCO Finland

Telephone, letter or other consultation without direct patient contact

3.3

31.0

127

416

M05BX04

ATC

denosumab; parenteral

3.3

31.0

125

406

XF400

NOMESCO Finland

ECG with 12 standard connections

2.4

30.9

244

1127

R4110

NOMESCO Finland

Physiotherapy

2.0

30.3

434

2542

XPX04

NOMESCO Finland

Angioscopy

59.8

30.2

J15.9

ICD-10 Finland

Bacterial pneumonia, unspecified

3.0

30.0

139

490

QX2XE

NOMESCO Finland

Ultrsound examination of soft tissue not elsewhere classified

4.7

29.4

152

UJF30

NOMESCO Finland

Ileoscopy through colon

2.6

29.3

186

774

B01AB05

ATC

enoxaparin; parenteral

2.0

29.1

485

2985

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

3.0

29.1

142

515

TND11

NOMESCO Finland

Injection of diagnostic or therapeutic substance in joint, wrist or hand

7.1

29.0

A02BC01

ATC

omeprazole; systemic

2.0

28.6

427

2527

E000001, ,

ATC

2.1

28.5

334

1810

L99

ICPC

Musculoskeletal disease other

5.3

28.5

113

DM1QA

NOMESCO Finland

Paranasal sinuses X-ray examination in one projection

3.6

28.5

287

XPX99

NOMESCO Finland

Other diagnostic examination of periferal vessel

3.4

28.5

108

337

ZXD30

NOMESCO Finland

Difficulties in perfomrming procedure

3.6

28.4

278

Z3231

NOMESCO Finland

Registered nurse

2.0

28.3

420

2481

WZA10

NOMESCO Finland

Extensive medical or dental certificate

6.7

28.2

C08CA02

ATC

felodipine; oral

2.9

28.2

145

541

GD1ED

NOMESCO Finland

Extensive high resolution CT examination of lungs

4.8

28.0

142

XW000

NOMESCO Finland

Bone marrow biopsy

4.0

27.5

213

D70.89

ICD-10 Finland

Neutropenic splenomegaly

7.0

27.3

QDB10

NOMESCO Finland

Major dressing of wound of skin of lower limb

3.7

27.2

252

NF1AA

NOMESCO Finland

Hip X-ray examination

2.8

27.2

149

575

L93.2

ICD-10 Finland

Other local lupus erythematosus

+∞

27.2

M35.8

ICD-10 Finland

Other specified systemic involvement of connective tissue

276.2

26.8

Z2221

NOMESCO Finland

Medical doctor

1.9

26.8

443

2706

A07EC01

ATC

sulfasalazine; oral, rectal

2.8

26.6

149

581

R70.0

ICD-10 Finland

Elevated erythrocyte sedimentation rate

5.7

26.4

R06.0

ICD-10 Finland

Dyspnoea

2.0

26.2

404

2407

J05AB11

ATC

valaciclovir; oral

2.2

25.8

259

1317

Z3229

NOMESCO Finland

Other healthcare associate professional

2.8

25.8

141

543

A02BC03

ATC

lansoprazole; oral

1.9

25.7

446

2762

UGC12

NOMESCO Finland

Flexible bronchoscopy

3.0

25.7

121

430

M79.7

ICD-10 Finland

Fibromyalgia

3.6

25.6

248

R21

ICD-10 Finland

Rash and other nonspecific skin eruption

3.3

25.3

100

320

A12AA04

ATC

calcium carbonate; oral

7.5

25.1

N08.5*M31.3

ICD-10 Finland

Glomerular disorders in Wegener's granulomatosis

+∞

25.1

TNX00

NOMESCO Finland

Puncture and needle biopsy of soft tissue, unspecified region

5.1

25.0

107

R91

ICD-10 Finland

Abnormal findings on diagnostic imaging of lung

2.7

25.0

147

588

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

2.9

24.9

127

471

J01FA06

ATC

roxithromycin; oral

1.8

24.7

616

4254

M81.9

ICD-10 Finland

Osteoporosis, unspecified

3.4

24.7

294

313

Kela drug reimbursment

Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab, tocilizumab and ustekinumab (rheumatoid diseases)

4.1

24.6

175

A46

ICD-10 Finland

Erysipelas

2.3

24.6

202

944

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.8

24.6

622

4314

L98.9

ICD-10 Finland

Disorder of skin and subcutaneous tissue, unspecified

6.0

24.4

L95

ICPC

Osteoporosis

3.6

24.4

246

B03XA02

ATC

darbepoetin alfa; parenteral

5.4

24.3

TNH11

NOMESCO Finland

Injection of diagnostic or therapeutic substance in ankle joint or foot joint

7.0

24.3

L27.0

ICD-10 Finland

Generalized skin eruption due to drugs and medicaments

6.3

24.2

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

2.1

24.1

294

1607

Z3226

NOMESCO Finland

Physiotherapist

2.1

24.1

294

1607

XQ848

NOMESCO Finland

Dermatological photography

4.2

23.8

157

NG1AA

NOMESCO Finland

Knee X-ray examination without contrast

2.3

23.8

208

998

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

2.2

23.5

228

1140

GD1AD

NOMESCO Finland

Thorax CT examination

3.2

23.5

324

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

2.2

23.4

217

1066

L01AA01

ATC

cyclophosphamide; systemic

34.0

23.4

D64.9

ICD-10 Finland

Anaemia, unspecified

2.6

23.2

149

621

R2130

NOMESCO Finland

Counselling and guidance which enhance independent living

2.6

23.1

140

568

A07AA02

ATC

nystatin; oral

2.9

23.1

113

410

NH3EA

NOMESCO Finland

Feet X-ray examination with load

4.8

23.0

111

N18.8

ICD-10 Finland

Other chronic renal failure

5.6

23.0

XCW99

NOMESCO Finland

Other investigative procedure of eye

2.4

23.0

173

777

M34.1

ICD-10 Finland

CR(E)ST syndrome

+∞

23.0

C08CA01

ATC

amlodipine; oral

1.8

22.9

506

3354

QDB05

NOMESCO Finland

Revision of wound of skin of lower limb

4.7

22.5

117

J05AB01

ATC

aciclovir; systemic

1.9

22.5

370

2234

D07AC13

ATC

mometasone; topical

1.8

22.5

440

2806

J01DB01

ATC

cefalexin; oral

2.1

22.2

1178

10070

L28

ICPC

Limited function/disability (L)

2.1

22.1

256

1369

WZC10

NOMESCO Finland

Written specialist consultation based on a referral from a dentist or a physician

3.2

22.0

294

D07AD01

ATC

clobetasol; topical

2.0

22.0

271

1483

M31.3

ICD-10 Finland

Wegener granulomatosis

+∞

21.9

R59.0

ICD-10 Finland

Localized enlarged lymph nodes

3.6

21.1

200

B99

ICD-10 Finland

Other and unspecified infectious diseases

5.1

21.0

M25.5

ICD-10 Finland

Pain in joint

1.8

21.0

502

3384

SPAT1148

SPAT

Treatment of chronic ulcer or burn

2.2

20.9

184

883

N03AX16

ATC

[U] pregabalin

1.9

20.9

350

2120

73491

ICD-8 Finland

Diffuse diseases of connective tissue, Collagenosis NUD

+∞

20.9

WW200

NOMESCO Finland

Immunization

4.3

20.8

129

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

2.2

20.7

191

934

L97

ICD-10 Finland

Ulcer of lower limb, not elsewhere classified

3.9

20.7

165

J84.9

ICD-10 Finland

Interstitial pulmonary disease, unspecified

5.4

20.7

L04AD02

ATC

tacrolimus; systemic

8.3

20.6

NH1AE

NOMESCO Finland

Ankle joint ultrasound examination

7.9

20.5

D07AB02

ATC

hydrocortisone butyrate; topical

1.8

20.4

447

2933

KAS10

NOMESCO Finland

Allogenic transplantation of kidney from cadaver donor

16.3

20.1

A41.0

ICD-10 Finland

Sepsis due to Staphylococcus aureus

5.6

20.1

XG412

NOMESCO Finland

Flow-volume spirometry with bronchospasmolysis

2.9

20.1

349

S81.8

ICD-10 Finland

Open wound of other parts of lower leg

3.9

20.1

155

I50.9

ICD-10 Finland

Heart failure, unspecified

2.3

19.9

156

712

UJF32

NOMESCO Finland

Coloscopy

1.8

19.8

364

2263

I32.8*M32.1

ICD-10 Finland

Pericarditis (in) systemic lupus erythematosus

+∞

19.8

M34.0

ICD-10 Finland

Progressive systemic sclerosis

+∞

19.8

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

2.4

19.8

139

604

NH3BA

NOMESCO Finland

Foot and toes extensive X-ray examination

3.3

19.7

245

281

Kela drug reimbursment

Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab and tocilizumab

3.8

19.6

167

TNG10

NOMESCO Finland

Puncture of knee

5.7

19.5

R29.8

ICD-10 Finland

Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems

2.4

19.4

138

603

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

1.7

19.4

547

3840

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

2.9

19.1

330

M31.5

ICD-10 Finland

Giant cell arteritis with polymyalgia rheumatica

55.8

19.0

TPH90

NOMESCO Finland

Removal of fixed intravenous catheter

6.4

18.9

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

2.2

18.8

168

809

TEA00

NOMESCO Finland

Biopsy of lip

8.2

18.8

N08.5*M31.1

ICD-10 Finland

Glomerular disorders in thrombotic thrombocytopenic purpura

+∞

18.8

N16.4*M32.1

ICD-10 Finland

Renal tubulo-interstitial disorders in systemic lupus erythematosus

+∞

18.8

ZX108

NOMESCO Finland

Inhalation

17.4

18.7

Z2446

NOMESCO Finland

Social worker

2.6

18.7

116

475

J01MA14

ATC

moxifloxacin; systemic

2.4

18.7

142

639

ND2BA

NOMESCO Finland

Hand and fingers extensive X-ray examination

4.1

18.6

127

PAW37

NOMESCO Finland

Biopsy of temporal artery

39.0

18.6

J84.1

ICD-10 Finland

Other interstitial pulmonary diseases with fibrosis

5.8

18.6

N03AX12

ATC

[U] gabapentin; oral

1.9

18.6

252

1419

TAB00

NOMESCO Finland

Lumbar puncture

2.9

18.5

314

AA1CG

NOMESCO Finland

Extensive MRI examination of brain with high intensity magnet

2.3

18.4

145

663

M35.7

ICD-10 Finland

Hypermobility syndrome

17.8

18.3

TGC00

NOMESCO Finland

Bronchial lavation

4.3

18.2

112

A02BC05

ATC

esomeprazole; systemic

1.7

18.2

592

4295

J02AC01

ATC

fluconazole; systemic

1.6

18.1

652

4849

M80.4

ICD-10 Finland

Drug-induced osteoporosis with pathological fracture

14.6

18.1

M01AH02

ATC

rofecoxib; oral

2.1

18.1

192

989

WZC00

NOMESCO Finland

Treatment plan or consultation

1.7

18.1

522

3669

AA1BG

NOMESCO Finland

Standard MRI examination of brain with high intensity magnet

2.3

18.1

149

694

N06AA09

ATC

amitriptyline; systemic

2.2

18.0

162

783

M05BA06

ATC

ibandronic acid; systemic

4.0

18.0

135

AA1AD

NOMESCO Finland

CT of head and brain

1.8

18.0

351

2215

M06.0

ICD-10 Finland

Seronegative rheumatoid arthritis

3.6

17.9

168

C02CA01

ATC

prazosin; oral

7.0

17.9

N02AA05

ATC

oxycodone; systemic

2.0

17.8

230

1271

7109X

ICD-9 Finland

Diffuse diseases of connective tissue, Unspecified diffuse connective tissue disease

+∞

17.7

M31.1

ICD-10 Finland

Thrombotic microangiopathy

+∞

17.7

G62.9

ICD-10 Finland

Polyneuropathy, unspecified

3.6

17.6

165

EP1AE

NOMESCO Finland

Neck ultrasound examination

2.6

17.5

104

417

B02.9

ICD-10 Finland

Zoster without complication

2.5

17.4

112

467

JN4AD

NOMESCO Finland

Body CT examination

2.3

17.4

137

626

J01DA01

ATC

[U] cefalexin

1.7

17.3

879

7091

Z03.5

ICD-10 Finland

Observation for other suspected cardiovascular diseases

2.4

17.3

127

562

XG470

NOMESCO Finland

Measurement of diffusion capastity of the lungs

4.0

17.2

126

CK2S4

NOMESCO Finland

Plain photography of ocular fundus

2.6

17.2

103

415

N32.9

ICD-10 Finland

Bladder disorder, unspecified

16.2

17.0

318

Kela drug reimbursment

Teriparatide

13.4

17.0

S97

ICPC

Chronic ulcer skin

2.8

17.0

329

Z49.0

ICD-10 Finland

Preparatory care for dialysis

14.3

16.8

A01AC01

ATC

triamcinolone; local oral

5.3

16.8

K90.0

ICD-10 Finland

Coeliac disease

3.4

16.7

181

R07.4

ICD-10 Finland

Chest pain, unspecified

1.7

16.6

384

2533

M31.9

ICD-10 Finland

Necrotizing vasculopathy, unspecified

172.0

16.5

L84

ICD-10 Finland

Corns and callosities

3.2

16.2

215

M03BA52

ATC

carisoprodol, combinations excl. psycholeptics; oral

3.1

16.2

231

K52.9

ICD-10 Finland

Noninfective gastroenteritis and colitis, unspecified

3.1

16.2

226

3AC01, ,

NOMESCO Finland

6.9

16.2

KA2AE

NOMESCO Finland

Ultrasound examination transplanted kidney

17.0

16.1

QC6S1

NOMESCO Finland

Photography of skin or subcutaneous tissue in hand

48.1

16.0

TQW80

NOMESCO Finland

Local dermatologic skincare

3.8

16.0

128

KA2AT

NOMESCO Finland

Biopsy of transplanted kidney with ultrasound guidance

21.2

16.0

A01

ICPC

Pain general/multiple sites

2.2

15.9

147

717

R51.80

ICD-10 Finland

Headache

1.8

15.8

255

1512

R87.6

ICD-10 Finland

Abnormal findings in specimens from female genital organs, abnormal cytological findings

2.0

15.8

175

915

WX203

NOMESCO Finland

Infraclavicular plexus blockade

3.9

15.7

125

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

1.9

15.7

204

1128

F02.89*M32.8

ICD-10 Finland

Dementia in systemic lupus erythematosus

+∞

15.7

6BA02, ,

NOMESCO Finland

26.6

15.6

WX002

NOMESCO Finland

Sedation and analgesia

1.8

15.6

271

1644

N17.9

ICD-10 Finland

Acute renal failure, unspecified

3.4

15.6

174

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

2.0

15.5

192

1044

M01CB01

ATC

sodium aurothiomalate; parenteral

5.3

15.4

K07.65

ICD-10 Finland

Temporomandibular joint-pain-dysfunction syndrome

5.4

15.2

JN4BD

NOMESCO Finland

Extensive body CT

2.2

15.1

140

683

D02AX

ATC

Other emollients and protectives

3.2

15.1

193

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

2.1

15.1

148

739

C02DE02, ,

ATC

6.9

14.9

J01AA02

ATC

doxycycline; systemic

1.7

14.7

1079

9333

I30.9

ICD-10 Finland

Acute pericarditis, unspecified

13.4

14.7

PG1DE

NOMESCO Finland

Other extensive ultrasound examination of artery

2.7

14.7

301

SAA03

NOMESCO Finland

Extended examination of mouth

1.6

14.7

564

4197

H02AB09

ATC

hydrocortisone; systemic

3.7

14.6

127

N02AC04

ATC

dextropropoxyphene; oral

3.3

14.6

176

M31.8

ICD-10 Finland

Other specified necrotizing vasculopathies

+∞

14.6

M02.9

ICD-10 Finland

Reactive arthropathy, unspecified

4.5

14.5

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.6

14.5

613

4658

69540

ICD-8 Finland

Erythematous condition, Lupus erythematosus

151.5

14.5

G73.7

ICD-10 Finland

Myopathy in other diseases classified elsewhere

151.5

14.5

L93

ICD-10 Finland

Lupus erythematosus

151.5

14.5

D50.9

ICD-10 Finland

Iron deficiency anaemia, unspecified

2.3

14.4

118

547

ZX140

NOMESCO Finland

Intra articular

6.0

14.3

WZB00

NOMESCO Finland

Telephone prescription or other care instructions

1.6

14.3

430

3014

JJ2AT

NOMESCO Finland

Biopsy of liver with ultrasound guidance

3.8

14.2

120

NH1AA

NOMESCO Finland

Ankle X-ray examination without contrast

2.3

14.2

110

498

C07AB07

ATC

bisoprolol; oral

1.6

14.2

592

4478

H05AA02

ATC

teriparatide; parenteral

12.1

14.1

205

Kela drug reimbursment

Chronic hypertension

1.7

14.1

299

1916

TPH20

NOMESCO Finland

Insertion of central venous catheter through subclavian or brachiocephalic vein

3.5

14.1

140

M81.4

ICD-10 Finland

Drug-induced osteoporosis

14.6

14.1

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

2.0

14.1

164

872

A02BA02

ATC

ranitidine; systemic

1.8

14.0

267

1659

137

Kela drug reimbursment

Uraemia requiring dialysis

11.0

14.0

I69.3

ICD-10 Finland

Sequelae of cerebral infarction

2.4

14.0

412

WZC05

NOMESCO Finland

Specialty-specific consultation based on referral by dentist or doctor

2.6

14.0

339

XCK00

NOMESCO Finland

Perimetry

2.5

13.9

376

A41.9

ICD-10 Finland

Sepsis, unspecified

3.3

13.9

161

A12BA01

ATC

potassium chloride; oral

3.0

13.9

219

C09AA02

ATC

enalapril; systemic

1.8

13.9

232

1388

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

1.8

13.8

256

1578

NA1EA

NOMESCO Finland

Cervical spine X-ray examination with flexion

4.8

13.8

D02BB01

ATC

betacarotene; oral

20.3

13.8

XA800

NOMESCO Finland

Neuropsychological investigation

2.8

13.7

266

ULA02

NOMESCO Finland

Kolposcopy

1.9

13.6

171

933

M33.9

ICD-10 Finland

Dermatopolymyositis, unspecified

+∞

13.6

C02KX01

ATC

bosentan; oral

+∞

13.6

K57.3

ICD-10 Finland

Diverticular disease of large intestine without perforation or abscess

1.8

13.5

241

1468

A01AB10

ATC

natamycin; local oral

3.2

13.5

169

I31.9

ICD-10 Finland

Disease of pericardium, unspecified

11.0

13.5

ZXE10

NOMESCO Finland

More than one and less than three hours

1.6

13.5

481

3501

M34.8

ICD-10 Finland

Other forms of systemic sclerosis

141.3

13.5

G73.7*M35.0

ICD-10 Finland

Myopathy in sicca syndrome [Sjögren]

141.3

13.5

B01AB04

ATC

dalteparin; parenteral

2.6

13.5

321

Z49.2

ICD-10 Finland

Other dialysis

13.0

13.4

Z50.9

ICD-10 Finland

Care involving use of rehabilitation procedure, unspecified

2.9

13.4

235

ZXA00

NOMESCO Finland

Right side

1.6

13.3

351

2375

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

1.6

13.3

400

2796

M05BA01

ATC

etidronic acid; systemic

11.6

13.3

ZXA05

NOMESCO Finland

Left side

1.7

13.2

322

2136

D02AE01

ATC

carbamide; topical

2.3

13.2

102

462

H19.3*M35.0

ICD-10 Finland

Keratoconjunctivitis sicca

40.5

13.2

M05.9

ICD-10 Finland

Seropositive rheumatoid arthritis, unspecified

3.6

13.2

122

K21.0

ICD-10 Finland

Gastro-oesophageal reflux disease with oesophagitis

2.1

13.2

140

720

XF404

NOMESCO Finland

Ambulatory ECG

2.2

13.1

117

562

190

Kela drug reimbursment

Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide

12.3

13.1

ZXX01

NOMESCO Finland

Extent of proceudre, 1 unit

6.0

13.1

SPAT1149

SPAT

Suture or treatment of traumatic wound

2.0

13.1

155

829

WX892

NOMESCO Finland

Monitored bed care

2.3

13.0

101

458

L01BB01, ,

ATC

28.7

13.0

N02BE01

ATC

paracetamol; systemic, rectal

1.9

12.9

1231

11164

WX408

NOMESCO Finland

General anesthesy, balanced

1.6

12.9

340

2298

D07AA02

ATC

hydrocortisone; topical

1.8

12.8

204

1201

B05DB

ATC

Hypertonic solutions

14.2

12.8

NA1AA

NOMESCO Finland

Cervical spine X-ray examination without contrast

3.0

12.8

202

L04AB01

ATC

etanercept; parenteral

4.3

12.7

F32.10

ICD-10 Finland

Moderate depressive episode without somatic syndrome

2.0

12.7

138

715

I70.2

ICD-10 Finland

Atherosclerosis of arteries of extremities

2.4

12.7

380

NB1AE

NOMESCO Finland

Shoulder ultrasound examination

3.9

12.7

L50.9

ICD-10 Finland

Urticaria, unspecified

2.7

12.6

260

N04.9

ICD-10 Finland

Nephrotic syndrome, unspecified

32.3

12.6

B05DA

ATC

Isotonic solutions

11.1

12.5

N08.5*M31.7

ICD-10 Finland

Glomerular disease states in microscopic polyangiitis

+∞

12.5

R4190

NOMESCO Finland

Nutritional therapy

2.8

12.5

221

D80.1

ICD-10 Finland

Nonfamilial hypogammaglobulinaemia

20.2

12.5

XQ841

NOMESCO Finland

Examination of dermatosis with microscope

131.2

12.5

G40.9

ICD-10 Finland

Epilepsy, unspecified

3.0

12.3

190

NA3CG

NOMESCO Finland

Lumbar spine extensive MRI examination with high intensity magnet

2.7

12.3

252

JN3AD

NOMESCO Finland

Abdominal CT examination

2.0

12.2

148

796

R80

ICD-10 Finland

Isolated proteinuria

9.7

12.2

P01AB01

ATC

metronidazole; oral, rectal

1.5

12.2

587

4536

SPAT1144

SPAT

Treatment of reopened or infected surgical wound

2.3

12.2

458

NH1CG

NOMESCO Finland

Ankle and foot extensive MRI examination with high intensity magnet

4.5

12.2

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

1.7

12.1

265

1705

GA1AE

NOMESCO Finland

Ultrasound examination of thorax

3.6

12.0

110

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

2.6

12.0

290

V03AE02

ATC

sevelamer; oral

21.5

12.0

NH3AE

NOMESCO Finland

Feet ultrasound examination

13.5

12.0

R06AE07

ATC

cetirizine; oral

1.5

11.9

633

4983

M46.9

ICD-10 Finland

Inflammatory spondylopathy, unspecified

4.9

11.9

D07BA04

ATC

hydrocortisone and antiseptics; topical

2.0

11.9

136

717

H53.1

ICD-10 Finland

Subjective visual disturbances

2.2

11.9

103

489

Z35.8

ICD-10 Finland

Supervision of other high-risk pregnancies

2.0

11.8

132

690

ZXE20

NOMESCO Finland

More than three and less than five hours

1.8

11.8

174

998

XG410

NOMESCO Finland

Flow-volume spirometry

2.8

11.8

217

N03AX14

ATC

levetiracetam; systemic

3.2

11.8

152

A63.0

ICD-10 Finland

Anogenital (venereal) warts

2.7

11.7

246

R59.1

ICD-10 Finland

Generalized enlarged lymph nodes

4.4

11.7

XF655

NOMESCO Finland

Measurement of heart muscle perfusion with exercise

3.5

11.7

117

K75.9

ICD-10 Finland

Inflammatory liver disease, unspecified

5.0

11.7

J01MA06

ATC

norfloxacin; oral

1.8

11.7

199

1193

R03AC02

ATC

salbutamol; inhalant

1.5

11.7

777

6393

H20.0

ICD-10 Finland

Acute and subacute iridocyclitis

2.6

11.6

253

ZXE06

NOMESCO Finland

Procedure duration 50 to 59 minutes

2.4

11.6

351

GD1BD

NOMESCO Finland

Thorax extensive CT-examination

2.5

11.6

314

A01AB04

ATC

amphotericin B; local oral

2.5

11.6

314

M01AH01

ATC

celecoxib; oral

1.7

11.5

245

1563

XFE00

NOMESCO Finland

Epicardial ultrasonography

3.8

11.5

J99.1

ICD-10 Finland

Respiratory disorders in other diffuse connective tissue disorders

+∞

11.5

N08.5*M30.0

ICD-10 Finland

Glomerular disorders in polyarteritis nodosa

+∞

11.5

7108X

ICD-9 Finland

Diffuse diseases of connective tissue, Other specified diffuse diseases of connective tissue

+∞

11.5

M33.2

ICD-10 Finland

Polymyositis

121.0

11.4

M13.0

ICD-10 Finland

Polyarthritis, unspecified

4.7

11.4

A01AB09

ATC

miconazole; local oral

2.0

11.4

128

670

H10.0

ICD-10 Finland

Mucopurulent conjunctivitis

2.1

11.4

108

532

SPAT1263

SPAT

Sampling

1.5

11.3

554

4278

H20.1

ICD-10 Finland

Chronic iridocyclitis

5.2

11.3

N30.0

ICD-10 Finland

Acute cystitis

1.7

11.3

247

1588

XLD00

NOMESCO Finland

Sytologyspecimen from mouth of uterus

1.8

11.2

196

1183

D01AE16

ATC

amorolfine; topical

1.9

11.2

162

923

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

1.7

11.2

217

1349

NB1AA

NOMESCO Finland

Shoulder X-ray examination without contrast

2.1

11.1

101

489

F32.11

ICD-10 Finland

Moderate depressive episode with somatic syndrome

2.9

11.1

190

JN3BD

NOMESCO Finland

Extensive abdominal CT

2.0

11.1

133

713

R5110

NOMESCO Finland

Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it

1.9

11.0

159

906

N03AF02

ATC

oxcarbazepine; oral

2.8

11.0

202

S01AA01

ATC

chloramphenicol; ophthalmic

2.4

10.9

335

NA2BG

NOMESCO Finland

Thoracal spine MRI examination with high intensity magnet

3.1

10.9

143

A12AA12

ATC

[U] calcium acetate

43.7

10.9

R05

ICD-10 Finland

Cough

1.6

10.9

294

1990

R76.0

ICD-10 Finland

Raised antibody titre

15.6

10.8

UKC02

NOMESCO Finland

Cystoscopy

1.8

10.8

158

904

G43.1

ICD-10 Finland

Migraine with aura [classical migraine]

2.0

10.8

122

641

111

Kela drug reimbursment

Epilepsy and comparable convulsive disorders

2.4

10.8

312

L17

ICPC

Foot/toe symptom/complaint

1.5

10.8

387

2796

S76

ICPC

Skin infection other

2.4

10.8

331

7140A

ICD-9 Finland

Rheumatoid arthritis and other inflammatory polyarthropathies, Rheumatoid arthritis[ARTHRITIS RHEUMATOIDES SEROPOSITIVA]

5.0

10.8

ZXE00

NOMESCO Finland

One hour or less

1.5

10.7

522

4016

M01AE03

ATC

ketoprofen; systemic, rectal

1.5

10.6

476

3598

I80.3

ICD-10 Finland

Phlebitis and thrombophlebitis of lower extremities, unspecified

2.6

10.6

229

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

1.7

10.6

209

1304

WW400

NOMESCO Finland

Plasmaferesis

60.5

10.6

R13

ICD-10 Finland

Dysphagia

2.1

10.6

484

H15.1

ICD-10 Finland

Episcleritis

4.0

10.6

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

1.5

10.6

692

5630

SHA03

NOMESCO Finland

Stomatognathic treatment, demanding

2.6

10.6

230

I35.1

ICD-10 Finland

Aortic (valve) insufficiency

2.6

10.5

242

B37.09

ICD-10 Finland

Unspecified candidal stomatitis

5.1

10.5

E000006, ,

ATC

2.1

10.5

105

528

FB1AD

NOMESCO Finland

CT examination of arteria pulmonalis

3.5

10.5

106

NA3AD

NOMESCO Finland

Lumbar spine and sacrum CT examination

3.1

10.4

147

K11.2

ICD-10 Finland

Sialoadenitis

2.7

10.4

208

D01AC20

ATC

imidazoles/triazoles in combination with corticosteroids; topical

1.6

10.4

296

2026

Z01.5

ICD-10 Finland

Diagnostic skin and sensitization tests

1.9

10.4

146

824

M33.1

ICD-10 Finland

Other dermatomyositis

+∞

10.4

S01XA18

ATC

ciclosporin; ophthalmic

5.5

10.4

SHA02

NOMESCO Finland

Stomatognathic treatment, basic

2.0

10.4

121

642

M01AE02

ATC

naproxen; oral, rectal

1.5

10.4

783

6534

SPAT1229

SPAT

Assessment of need for aid

2.1

10.3

100

496

F45.4

ICD-10 Finland

Persistent somatoform pain disorder

3.5

10.3

102

E000007, ,

ATC

2.2

10.3

422

ZXE11

NOMESCO Finland

Procedure duration 60 to 89 minutes

2.1

10.3

449

R23.3

ICD-10 Finland

Spontaneous ecchymoses

3.3

10.3

117

A04

ICPC

Weakness/tiredness general

1.7

10.3

198

1228

I82.88

ICD-10 Finland

Embolism and thrombosis of other specified veins

3.7

10.3

NA2AA

NOMESCO Finland

Thoracal spine X-ray examination without contrast

3.0

10.2

149

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

1.7

10.2

194

1199

S01BA04

ATC

prednisolone; ophthalmic

3.2

10.2

123

K44.9

ICD-10 Finland

Diaphragmatic hernia without obstruction or gangrene

2.0

10.2

109

562

R52.9

ICD-10 Finland

Pain, unspecified

1.9

10.1

132

729

K07.60

ICD-10 Finland

Snapping jaw

2.1

10.1

440

182

Kela drug reimbursment

Brivaracetam, eslikarbazepin, gabapentin, lacosamide, levetiracetam, perampanel, pregabalin, tiagabin and zonisamide

3.3

10.0

119

N05CF01

ATC

zopiclone; oral

1.5

10.0

418

3108

M84.3

ICD-10 Finland

Stress fracture, not elsewhere classified

3.9

10.0

N02AJ06

ATC

codeine and paracetamol; systemic

1.5

10.0

557

4384

E000002, ,

ATC

1.8

9.9

156

912

I34.09

ICD-10 Finland

Mitral (valve) insufficiency

2.7

9.9

208

FM1BE

NOMESCO Finland

Cardiac ultrasound examination through oesophagus

2.3

9.9

344

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.4

9.8

704

5794

I25.1

ICD-10 Finland

Atherosclerotic heart disease

1.7

9.8

198

1242

ZXD05

NOMESCO Finland

Urgent procedure

1.5

9.8

393

2896

LCA06

NOMESCO Finland

Biopsy of endometrium

1.7

9.8

200

1260

TPX10

NOMESCO Finland

Implantation of vascular injection port

2.9

9.8

164

J01.0

ICD-10 Finland

Acute maxillary sinusitis

1.5

9.7

362

2628

NE1AA

NOMESCO Finland

Pelvis X-ray examination

2.1

9.7

474

NA1BG

NOMESCO Finland

Cervical spine MRI examination with high intensity magnet

2.2

9.7

380

S01KA02

ATC

hypromellose; ophthalmic

3.4

9.6

102

QAA25

NOMESCO Finland

Destruction of lesion of head or neck

3.3

9.6

107

A02BA04

ATC

nizatidine; systemic

2.0

9.6

503

R42

ICD-10 Finland

Dizziness and giddiness

1.6

9.6

287

1985

T78.4

ICD-10 Finland

Allergy, unspecified

2.3

9.5

343

R81

ICPC

Pneumonia

2.7

9.5

195

G40.22

ICD-10 Finland

Complex partial epileptic seizure with secondary generalization

3.4

9.5

103

Z96.1

ICD-10 Finland

Presence of intraocular lens

1.7

9.5

166

1002

M79.6

ICD-10 Finland

Pain in limb

1.4

9.5

569

4527

WX110

NOMESCO Finland

Infiltration anesthesia

1.5

9.5

962

8418

L71.9

ICD-10 Finland

Rosacea, unspecified

2.9

9.4

156

R1250

NOMESCO Finland

Evaluation of functional capability

3.1

9.4

129

CJE20

NOMESCO Finland

Phakoemulsification with implantation of artificial lens in posterior chamber

1.5

9.4

342

2467

UJD02

NOMESCO Finland

Gastroscopy

2.4

9.4

281

M35.2

ICD-10 Finland

Behçet disease

+∞

9.4

M31.7

ICD-10 Finland

Microscopic polyangiitis

+∞

9.4

R60.0

ICD-10 Finland

Localized oedema

1.8

9.3

149

876

Z50.1

ICD-10 Finland

Other physical therapy

2.2

9.3

353

L98.4

ICD-10 Finland

Chronic ulcer of skin, not elsewhere classified

3.6

9.3

L02.4

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of limb

2.7

9.2

192

NH3FA

NOMESCO Finland

Weight-bearing X-ray of foot

3.2

9.2

115

WW500

NOMESCO Finland

Blood transfusion

2.5

9.2

234

C07AB02

ATC

metoprolol; systemic

1.6

9.2

232

1541

FN1AC

NOMESCO Finland

Angiography of heart and/or coronary arteries

1.6

9.1

225

1485

M19.2

ICD-10 Finland

Other secondary arthrosis

4.3

9.1

NK5AT

NOMESCO Finland

Joint injection with ultrasound guidance not elsewhere classified

5.1

9.1

R4180

NOMESCO Finland

Podiatric therapy

4.5

9.1

TNG11

NOMESCO Finland

Injection of diagnostic or therapeutic substance in knee

4.5

9.1

A07AA09

ATC

vancomycin; oral

4.6

9.1

I48

ICD-10 Finland

Atrial fibrillation and flutter

1.7

9.1

199

1276

K76.9

ICD-10 Finland

Liver disease, unspecified

4.0

9.1

7890A

ICD-9 Finland

Other symptoms involving abdomen and pelvis, Abdominal pain

2.1

9.1

397

R68.2

ICD-10 Finland

Dry mouth, unspecified

10.1

9.0

ZZA00

NOMESCO Finland

Split skin graft

3.1

9.0

122

H20.9

ICD-10 Finland

Iridocyclitis, unspecified

4.1

9.0

C01DA02

ATC

glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal

1.7

9.0

187

1183

SPAT1255

SPAT

Intravenous administration of medicine

2.1

9.0

385

M01AB55

ATC

diclofenac, combinations; oral

2.0

9.0

474

H05BA01

ATC

calcitonin (salmon synthetic); nasal, parenteral

2.7

9.0

172

XF600

NOMESCO Finland

Bloodpressure measurement

2.1

9.0

392

EBA10

NOMESCO Finland

Operative extraction of tooth

1.7

9.0

165

1010

PJA10

NOMESCO Finland

Exploration of lymph nodes

4.2

8.9

H26.4

ICD-10 Finland

After-cataract

1.9

8.9

118

654

SBA00

NOMESCO Finland

Microbiological examinations

2.9

8.8

145

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

1.7

8.8

177

1108

K13.79

ICD-10 Finland

Change in the oral mucosa UNS

2.8

8.8

162

AA1DG

NOMESCO Finland

Very extensive MRI examination of brain with high intensity magnet

2.7

8.8

185

K99

ICPC

Cardiovascular disease other

3.2

8.8

108

A41.5

ICD-10 Finland

Sepsis due to other Gram-negative organisms

2.7

8.8

168

I83.0

ICD-10 Finland

Varicose veins of lower extremities with ulcer

3.3

8.8

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.0

8.8

457

J01MA01

ATC

ofloxacin; systemic

2.0

8.7

101

535

N06AB04

ATC

citalopram; systemic

1.5

8.7

281

1973

M35

ICD-10 Finland

Other systemic involvement of connective tissue

50.3

8.7

UJF92

NOMESCO Finland

Capsular endoscopy

3.2

8.7

109

C03DA01

ATC

spironolactone; oral

1.8

8.7

134

780

A40.3

ICD-10 Finland

Sepsis due to Streptococcus pneumoniae

7.7

8.7

PBL10

NOMESCO Finland

Construction of arteriovenous fistula from radial artery

7.7

8.7

D06BX01

ATC

metronidazole; topical

1.7

8.6

162

996

FM1DE

NOMESCO Finland

Doppler ultrasound examination of heart

1.9

8.6

110

602

R04.0

ICD-10 Finland

Epistaxis

2.0

8.6

446

M01AX01

ATC

nabumetone; oral

2.4

8.6

254

LFB10

NOMESCO Finland

Excision of lesion of vulva or perineum

4.0

8.6

A28

ICPC

Limited function/disability NOS

1.7

8.6

185

1180

KA9AE

NOMESCO Finland

Ultrasound examination transplanted kidney

16.4

8.6

G03.9

ICD-10 Finland

Meningitis, unspecified

16.4

8.6

D68.9

ICD-10 Finland

Coagulation defect, unspecified

10.1

8.5

TKC20

NOMESCO Finland

Catheterisation of bladder

2.1

8.5

366

C08CA13

ATC

lercanidipine; oral

1.7

8.5

175

1104

SPAT1325

SPAT

Vaccination

1.4

8.5

404

3067

EB1WA, ,

NOMESCO Finland

7.4

8.5

X58

ICD-10 Finland

Exposure to other specified factors

1.7

8.4

179

1137

J45.1

ICD-10 Finland

Nonallergic asthma

2.0

8.4

514

NDL52

NOMESCO Finland

Tenosynovectomy of hand

4.9

8.4

ZXX02

NOMESCO Finland

Extent of procedure, 2 units

3.8

8.4

D06BB10

ATC

imiquimod; topical

2.2

8.4

342

J99.1*M31.3

ICD-10 Finland

Respiratory disorders in Wegener's granulomatosis

+∞

8.3

4AA26, ,

NOMESCO Finland

+∞

8.3

58199

ICD-8 Finland

Nephrotic syndrome

+∞

8.3

4430A

ICD-9 Finland

Other peripheral vascular disease, Raynaud's syndrome

+∞

8.3

7100A, ,

ICD-10 Finland

+∞

8.3

M31.0

ICD-10 Finland

Hypersensitivity angiitis

+∞

8.3

SAA04

NOMESCO Finland

Special examination of mouth

2.1

8.3

383

A04.7

ICD-10 Finland

Enterocolitis due to Clostridium difficile

3.1

8.3

112

5BA08, ,

NOMESCO Finland

8.6

8.3

NG1EA

NOMESCO Finland

Knee X-ray examination with wrench

3.7

8.3

RJ421, ,

NOMESCO Finland

10.8

8.3

K73.2

ICD-10 Finland

Chronic active hepatitis, not elsewhere classified

10.8

8.3

320

Kela drug reimbursment

Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide

10.8

8.3

B34.9

ICD-10 Finland

Viral infection, unspecified

2.7

8.3

162

N12

ICD-10 Finland

Tubulo-interstitial nephritis, not specified as acute or chronic

4.1

8.3

G45.9

ICD-10 Finland

Transient cerebral ischaemic attack, unspecified

2.0

8.3

467

CK2X4

NOMESCO Finland

Optical coherence tomography (OCT) of ocular fundus

1.8

8.3

122

700

E86

ICD-10 Finland

Volume depletion

3.2

8.2

Z2445

NOMESCO Finland

Psychologist

2.4

8.2

241

TQW40

NOMESCO Finland

Remowal of suture of skin

1.9

8.2

511

NG1AE

NOMESCO Finland

Knee joint ultrasound exmination

3.7

8.2

NA1BA

NOMESCO Finland

Cervical spine extensive X-ray examination without contrast

6.5

8.2

SPAT1222

SPAT

Counselling/guidance promoting independent living

1.6

8.2

180

1154

PJ2AE

NOMESCO Finland

Lymphnode ultrasound examination

7.6

8.2

ZZH21

NOMESCO Finland

Graft of patients own bone, small pieces

3.1

8.2

108

SPAT1256

SPAT

Intramuscular and subcutaneous injection

1.4

8.1

505

4012

ZXA10

NOMESCO Finland

Bilateral

1.6

8.1

227

1541

E78.0

ICD-10 Finland

Pure hypercholesterolaemia

0.6

8.1

111

1876

L20

ICPC

Joint symptom/complaint NOS

2.4

8.1

242

RD210, ,

NOMESCO Finland

3.4

8.1

4859X

ICD-9 Finland

Bronchopneumonia, organism unspecified[PNEUMONIA NUD]

3.4

8.1

A03FA01

ATC

metoclopramide; systemic, rectal

1.5

8.1

302

2183

R50.0

ICD-10 Finland

Fever with chills

33.5

8.1

A07EA06

ATC

budesonide; oral, local oral

2.4

8.1

224

ZXE04

NOMESCO Finland

Procedure duration 30 to 39 minutes

2.0

8.1

415

N03.9

ICD-10 Finland

Chronic nephritic syndrome, unspecified

11.8

8.1

RT271, ,

NOMESCO Finland

17.3

8.1

LEB00

NOMESCO Finland

Biopsy of vagina

3.0

8.1

114

K59.1

ICD-10 Finland

Functional diarrhoea

2.1

8.0

402

K21.9

ICD-10 Finland

Gastro-oesophageal reflux disease without oesophagitis

1.7

8.0

142

859

LDA20

NOMESCO Finland

Biopsy of vaginal cervix

1.9

8.0

105

580

71239

ICD-8 Finland

Rheumatoid arthritis and allied conditions, Arthritis rheumatoides NUD

6.3

8.0

NHQ40

NOMESCO Finland

Amputation of toe

4.2

8.0

S29

ICPC

Skin symptom/complaint other

1.5

8.0

239

1648

S32.0

ICD-10 Finland

Fracture of lumbar vertebra

2.6

8.0

177

QAA05

NOMESCO Finland

Incision for biopsy of skin of head or neck

3.0

7.9

110

H26.2

ICD-10 Finland

Complicated cataract

3.7

7.9

R2120

NOMESCO Finland

Counselling and guidance concerning rehabilitation services and social security

6.6

7.9

NDB78

NOMESCO Finland

Prosthetic replacement of several of finger or metacarpal

13.1

7.9

TK810

NOMESCO Finland

Hemofiltration

13.1

7.9

RT274, ,

NOMESCO Finland

13.1

7.9

GA4YT

NOMESCO Finland

Puncture of pleura with ultrasound guidance

2.7

7.9

149

I26.9

ICD-10 Finland

Pulmonary embolism without mention of acute cor pulmonale

2.2

7.9

317

H10.9

ICD-10 Finland

Conjunctivitis, unspecified

1.9

7.9

497

X59

ICD-10 Finland

Exposure to unspecified factor

1.5

7.8

234

1613

J94.8

ICD-10 Finland

Other specified pleural conditions

4.1

7.8

R02

ICPC

Shortness of breath/dyspnoea

1.7

7.8

160

1008

RT272, ,

NOMESCO Finland

9.5

7.8

SCA02

NOMESCO Finland

Preventive oral health care

1.7

7.8

139

844

J10.1

ICD-10 Finland

Influenza with other respiratory manifestations, seasonal influenza virus identified

3.7

7.8

A03

ICPC

Fever

1.6

7.7

220

1499

SPAT1220

SPAT

Assessment of need for rehabilitation and/or rehabilitation plan

2.0

7.7

408

I63.9

ICD-10 Finland

Cerebral infarction, unspecified

1.8

7.7

106

595

NHG76

NOMESCO Finland

Arthroplasty of other tarsometatarsal joint

3.6

7.7

H26.02

ICD-10 Finland

Presenil cataract

2.7

7.7

145

NE1BG

NOMESCO Finland

Pelvic, hip and femur MRI examination with high intensity magnet

2.5

7.7

186

L95.9

ICD-10 Finland

Vasculitis limited to skin, unspecified

7.5

7.7

ZXD10

NOMESCO Finland

Scheduled procedure

1.4

7.7

483

3839

C07AG02

ATC

carvedilol; oral

2.1

7.6

341

TFC00

NOMESCO Finland

Catheterisation of right atrium or ventricle

4.0

7.6

B03XA01

ATC

erythropoietin; parenteral

6.7

7.6

L53.9

ICD-10 Finland

Erythematous condition, unspecified

3.6

7.6

L94.8

ICD-10 Finland

Other specified localized connective tissue disorders

25.2

7.6

R76.8

ICD-10 Finland

Other specified abnormal immunological findings in serum

25.2

7.6

R07.1

ICD-10 Finland

Chest pain on breathing

3.5

7.6

QDG20

NOMESCO Finland

Operation for chronic ulcer or fistula of skin of lower limb

6.2

7.5

TNE25

NOMESCO Finland

Drill biopsy of bone marrow, pelvis

4.1

7.5

TQW99

NOMESCO Finland

Other minor procedure on skin

2.2

7.5

296

TJA35

NOMESCO Finland

Removal of peritoneal dialysis catheter

10.1

7.5

R53

ICD-10 Finland

Malaise and fatigue

1.5

7.5

309

2274

L71.8

ICD-10 Finland

Other rosacea

3.1

7.5

103

I25.9

ICD-10 Finland

Chronic ischaemic heart disease, unspecified

1.9

7.4

456

S01GX01

ATC

cromoglicic acid; ophthalmic

1.5

7.4

290

2111

NHG80

NOMESCO Finland

Fusion of first tarsometatarsal joint

2.3

7.4

252

L94.9

ICD-10 Finland

Localized connective tissue disorder, unspecified

80.5

7.4

C09CA06

ATC

candesartan; oral

1.5

7.4

298

2182

TNX32

NOMESCO Finland

Custom moulded splint, unspecified region

2.1

7.4

352

B37.08

ICD-10 Finland

Other candidal stomatitis

6.0

7.4

Z71.8

ICD-10 Finland

Other specified counselling

1.4

7.4

411

3194

K29.3

ICD-10 Finland

Chronic superficial gastritis

2.5

7.4

178

Z03.3

ICD-10 Finland

Observation for suspected nervous system disorder

2.0

7.4

415

M80.9

ICD-10 Finland

Unspecified osteoporosis with pathological fracture

3.0

7.4

104

S01CA01

ATC

dexamethasone and antiinfectives; ophthalmic

1.4

7.4

418

3259

J01EA01

ATC

trimethoprim; systemic

1.4

7.3

374

2862

SBB00

NOMESCO Finland

Clinical photography of mouth and teeth

2.4

7.3

197

I68.2*M32.1

ICD-10 Finland

Cerebral arteritis in systemic lupus erythematosus

+∞

7.3

N08.5*M31.0

ICD-10 Finland

Glomerular disorders in Goodpasture's syndrome

+∞

7.3

6954B

ICD-9 Finland

Erythematous conditions, Lupus erythematosus[LUPUS ERYTHEMATOSUS DISCOIDES DISSEMINATUS]

+∞

7.3

74310

ICD-8 Finland

Other congenital anomalies of nervous system, Microcephalus

+∞

7.3

RJ410, ,

NOMESCO Finland

9.4

7.3

QXB99

NOMESCO Finland

Other procedure to treat skin wound, unspecified location

3.2

7.3

I34.00

ICD-10 Finland

Mitral (valve) incompetence NOS or of specified cause, except rheumatic

3.4

7.3

G04.9

ICD-10 Finland

Encephalitis, myelitis and encephalomyelitis, unspecified

15.8

7.2

I25.2

ICD-10 Finland

Old myocardial infarction

2.3

7.2

236

N04.0

ICD-10 Finland

Nephrotic syndrome, minor glomerular abnormality

30.2

7.2

SHB00

NOMESCO Finland

Preparing and fitting the occlusal splint in the mouth

1.6

7.1

155

990

D06BB04

ATC

podophyllotoxin; topical

2.0

7.1

378

GD1CD

NOMESCO Finland

Thorax extensive CT-examination

6.6

7.1

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

1.4

7.1

357

2722

N05BA01

ATC

diazepam; systemic, rectal

1.6

7.1

171

1121

K65.0

ICD-10 Finland

Acute peritonitis

5.7

7.1

N05CD07

ATC

temazepam; oral

1.7

7.1

138

858

N05BA04

ATC

oxazepam; oral

1.4

7.1

336

2537

NA3EA

NOMESCO Finland

Lumbar spine X-ray examination with flexion

2.5

7.1

182

WZA90

NOMESCO Finland

Other medical or dental certificate

1.4

7.1

302

2236

6489X

ICD-9 Finland

Other current conditions in the mother classifiable elsewhere but complicating pregnancy, childbirth and the puerperium, Other current conditions classifiable elsewhere

8.8

7.1

SPAT1254

SPAT

Administration of medicine

1.6

7.0

169

1107

C01DA14

ATC

isosorbide mononitrate; oral

1.7

7.0

138

859

E03.9

ICD-10 Finland

Hypothyroidism, unspecified

1.6

7.0

186

1247

J01XE01

ATC

nitrofurantoin; oral

3.0

7.0

102

ZX100

NOMESCO Finland

Oral

3.4

7.0

SPA00

NOMESCO Finland

Changing form of teeth in prepation for prosthodontic work

2.2

7.0

259

N06AX21

ATC

duloxetine; oral

1.6

7.0

164

1069

Z01.2

ICD-10 Finland

Dental examination

1.4

7.0

595

4946

D06AX01

ATC

fusidic acid; topical

1.7

6.9

122

737

QBA99

NOMESCO Finland

Other local destruction of skin of trunk

6.4

6.9

WX204

NOMESCO Finland

Axillary plexus blockaced

2.3

6.9

221

LC2BE

NOMESCO Finland

Transvaginal ultrasound examination of uterus, parametria and lower abdomen

1.4

6.9

428

3379

PH1AE

NOMESCO Finland

Ultrasound examination of upper extremity veins

3.1

6.9

F43.22

ICD-10 Finland

Adaptation disorder with mixed anxiety and depression

2.0

6.9

341

D59.1

ICD-10 Finland

Other autoimmune haemolytic anaemias

7.6

6.9

RJ511, ,

NOMESCO Finland

13.8

6.9

N32.1

ICD-10 Finland

Vesicointestinal fistula

13.8

6.9

O99.7

ICD-10 Finland

Diseases of the skin and subcutaneous tissue complicating pregnancy, childbirth and the puerperium

13.8

6.9

WYA30

NOMESCO Finland

Treatment of a patient needing special arrangements

1.8

6.9

105

609

K08.1

ICD-10 Finland

Loss of teeth due to accident, extraction or local periodontal disease

1.7

6.9

137

856

R05

ICPC

Cough

1.4

6.9

316

2370

TDM10

NOMESCO Finland

Puncture of maxillary antrum

2.2

6.9

248

RS221, ,

NOMESCO Finland

3.4

6.8

S01

ICPC

Pain/tenderness of skin

2.1

6.8

288

AA1DM

NOMESCO Finland

Very extensive MRI examination of brain with 3 Tesla magnet

4.1

6.8

K02.1

ICD-10 Finland

Caries of dentine

1.3

6.8

775

6719

129

Kela drug reimbursment

Idiopathic thrombocytopaenia or granulocytopenia

11.0

6.8

B25.9

ICD-10 Finland

Cytomegaloviral disease, unspecified

11.0

6.8

I20.00

ICD-10 Finland

Unstable angina

2.7

6.8

126

TK820

NOMESCO Finland

Peritoneal dialysis

9.4

6.8

WX404

NOMESCO Finland

Intravenous generell anesthesy

1.5

6.8

270

1971

ZZH31

NOMESCO Finland

Bone allograft, small pieces

4.3

6.8

I15.9

ICD-10 Finland

Secondary hypertension, unspecified

4.3

6.8

I27.9

ICD-10 Finland

Pulmonary heart disease, unspecified

16.8

6.7

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.4

6.7

366

2825

ZXE13

NOMESCO Finland

Procedure duration 90 to 119 minutes

2.2

6.7

257

I77.6

ICD-10 Finland

Arteritis, unspecified

22.6

6.7

TJA33

NOMESCO Finland

Percutaneous introduction of peritoneal dialysis catheter

22.6

6.7

J09

ICD-10 Finland

Influenza due to identified zoonotic or pandemic influenza virus

2.7

6.7

133

Z46.8

ICD-10 Finland

Fitting and adjustment of other specified devices

2.6

6.7

139

NH1BG

NOMESCO Finland

Ankle and foot MRI examination with high intensity magnet

2.9

6.7

105

A03FA02

ATC

cisapride; oral, rectal

1.8

6.6

511

M54.9

ICD-10 Finland

Dorsalgia, unspecified

1.6

6.6

161

1057

C09CA01

ATC

losartan; oral

1.4

6.6

289

2145

D69.9

ICD-10 Finland

Haemorrhagic condition, unspecified

7.8

6.6

V03AE01

ATC

polystyrene sulfonate; oral

5.5

6.6

JN6DR

NOMESCO Finland

PET-CT of whole body metabolism

5.9

6.6

M79.1

ICD-10 Finland

Myalgia

1.5

6.6

197

1355

R11

ICD-10 Finland

Nausea and vomiting

1.7

6.6

115

693

G40.29

ICD-10 Finland

Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures

2.9

6.6

100

E000003, ,

ATC

2.1

6.6

292

XJC00

NOMESCO Finland

Oesophageal manometry

12.3

6.6

B01AC04

ATC

clopidogrel; oral

1.6

6.6

154

1003

H57.1

ICD-10 Finland

Ocular pain

2.2

6.6

266

XCH00

NOMESCO Finland

Eye pressure measurement

2.2

6.6

266

183

Kela drug reimbursment

Lamotrigin and topiramate

4.2

6.6

F33.11

ICD-10 Finland

Recurrent depression, moderate episode of somatic syndrome

2.5

6.6

164

NK6PA

NOMESCO Finland

Measurement of bone density from one location with X-ray

8.7

6.6

ZXC12

NOMESCO Finland

Pulse colorlaser

8.7

6.6

M54.5

ICD-10 Finland

Low back pain

1.4

6.6

471

3803

K22.4

ICD-10 Finland

Dyskinesia of oesophagus

6.2

6.5

EB1CI

NOMESCO Finland

Cone beam imaging of teeth and jaws (3-4 quarters)

5.3

6.5

ZXE03

NOMESCO Finland

Procedure duration 20 to 29 minutes

1.9

6.5

399

G04BE03

ATC

sildenafil; oral

5.7

6.5

JF1CG

NOMESCO Finland

Extensive MRI of small bowel

5.7

6.5

C09AA05

ATC

ramipril; oral

1.5

6.5

256

1866

N03AX09

ATC

lamotrigine; oral

2.0

6.4

364

L14

ICPC

Leg/thigh symptom/complaint

1.8

6.4

103

607

N25.0

ICD-10 Finland

Renal osteodystrophy

14.4

6.4

H25.8

ICD-10 Finland

Other senile cataract

1.7

6.4

110

661

M48.0

ICD-10 Finland

Spinal stenosis

1.6

6.4

139

889

C02AC05

ATC

moxonidine; oral

2.2

6.4

236

K29

ICPC

Cardiovascular sympt/complt other

2.2

6.4

223

J01DA09

ATC

[U] cefadroxil

1.4

6.4

332

2542

R56.8

ICD-10 Finland

Other and unspecified convulsions

2.1

6.4

276

C08DB01

ATC

diltiazem; oral

2.1

6.3

263

N39.1

ICD-10 Finland

Persistent proteinuria, unspecified

8.2

6.3

JN1CG

NOMESCO Finland

Extensive MRI examination of upper part of abdomen with high intensity magnet

2.6

6.3

131

JL5BG

NOMESCO Finland

MRI examinaiton of bile and pancreas ducts with high intesity magnet

2.6

6.3

137

A08

ICPC

Swelling

2.0

6.3

325

F32.9

ICD-10 Finland

Depressive episode, unspecified

1.6

6.3

171

1152

M79.3

ICD-10 Finland

Panniculitis, unspecified

11.1

6.3

S22.0

ICD-10 Finland

Fracture of thoracic vertebra

2.9

6.3

103

120

Kela drug reimbursment

Hypogammaglobulinaemia

18.1

6.3

286

Kela drug reimbursment

Ciclosporin eye drop

+∞

6.3

M30.8

ICD-10 Finland

Other conditions related to polyarteritis nodosa

+∞

6.3

M30.1

ICD-10 Finland

Polyarteritis with lung involvement [Churg-Strauss]

+∞

6.3

J99.1*M35.0

ICD-10 Finland

Respiratory disorders in sicca syndrome [Sjögren]

+∞

6.3

N085, M328,

ICD-10 Finland

+∞

6.3

M31.2

ICD-10 Finland

Lethal midline granuloma

+∞

6.3

N085M, ,

ICD-10 Finland

+∞

6.3

O9989, M329,

ICD-10 Finland

+∞

6.3

N085, M318,

ICD-10 Finland

+∞

6.3

E32.9

ICD-10 Finland

Disease of thymus, unspecified

+∞

6.3

NAG62

NOMESCO Finland

Posterior fusion of lumbar spine with fixation, 2-3 vertebraea

2.8

6.2

109

L04AB04

ATC

adalimumab; parenteral

2.6

6.2

132

7148X

ICD-9 Finland

Rheumatoid arthritis and other inflammatory polyarthropathies, Other specified inflammatory polyarthropathies

26.8

6.2

NHG77

NOMESCO Finland

Arthroplasty of interphalangeal tarsal joint(s)

2.6

6.2

138

WX320

NOMESCO Finland

Spinalanesthesy

1.4

6.2

298

2249

H53.4

ICD-10 Finland

Visual field defects

2.8

6.2

104

M01AX17

ATC

nimesulide; oral

1.4

6.2

288

2162

K11.70

ICD-10 Finland

Hypoptyalism

6.3

6.2

CA1CG

NOMESCO Finland

Eye and orbita extensive MRI examination with high intensity magnet

5.4

6.2

M06

ICD-10 Finland

Other rheumatoid arthritis

5.8

6.1

NB1BA

NOMESCO Finland

Shoulder extensive X-ray examination without contrast

2.3

6.1

188

N87.1

ICD-10 Finland

Moderate cervical dysplasia

2.5

6.1

157

DFF00

NOMESCO Finland

Pure tone audiometry

1.7

6.1

118

731

F32.2

ICD-10 Finland

Severe depressive episode without psychotic symptoms

1.8

6.1

524

L29

ICPC

Musculoskeletal sympt/complt other

1.7

6.1

106

638

N91.1

ICD-10 Finland

Secondary amenorrhoea

3.0

6.1

JAK10

NOMESCO Finland

Laparotomy and insertion of peritoneal dialysis catheter

7.7

6.1

J44.8

ICD-10 Finland

Other specified chronic obstructive pulmonary disease

1.8

6.1

465

B01AB10

ATC

tinzaparin; parenteral

1.6

6.1

125

787

LDC03

NOMESCO Finland

Conisation of cervix uteri using diathermy or laser

2.0

6.1

322

I50.1

ICD-10 Finland

Left ventricular failure

2.3

6.1

195

M51.1

ICD-10 Finland

Lumbar and other intervertebral disc disorders with radiculopathy

1.5

6.1

177

1210

M81.8

ICD-10 Finland

Other osteoporosis

3.8

6.1

JJ1LE

NOMESCO Finland

Ultrasound elastography of liver

3.8

6.1

N05BB01

ATC

hydroxyzine; systemic

1.8

6.1

473

SFA10

NOMESCO Finland

One-surface restoration

1.3

6.1

714

6174

N06AX11

ATC

mirtazapine; oral

1.4

6.1

434

3492

K75.4

ICD-10 Finland

Autoimmune hepatitis

12.6

6.1

H35.39

ICD-10 Finland

Degeneration of macula and posterior pole

2.4

6.1

158

PF1AT

NOMESCO Finland

Intravascular dilatation of arteries of knee, lower leg and ankle (PTA)

8.6

6.1

N90.2

ICD-10 Finland

Severe vulvar dysplasia, not elsewhere classified

8.6

6.1

C02EA02, ,

ATC

2.3

6.1

183

JA1AE

NOMESCO Finland

Ultrasound examination of groin and abdominal wall

3.1

6.1

H25.0

ICD-10 Finland

Senile incipient cataract

1.9

6.1

401

NXL00

NOMESCO Finland

Biopsy of muscle

10.1

6.0

NE1BA

NOMESCO Finland

Pelvis extensive X-ray examination

3.3

6.0

RS220, ,

NOMESCO Finland

3.3

6.0

R2110

NOMESCO Finland

Giving the first information

1.8

6.0

550

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

454

256

25.83

307.65

2.0

1.1

14.44

3.31

u/ml

4.56

180

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

459

281

23.88

307.65

2.0

1.1

33.75

7.01

u/ml

2.86

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

389

187

28.48

307.65

1.9

1.1

2.12

9.93

u/ml

—

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

824

285

69.40

307.65

6.7

1.1

0.18

0.25

g/l

25.05

794

268

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

456

252

26.42

307.65

2.0

1.1

19.88

2.11

u/ml

3.40

153

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

824

301

65.64

307.65

6.6

1.2

1.03

1.22

g/l

19.27

800

282

(3037522) Nuclear Ab [Titer] in Serum

788

1506

10.75

307.65

2.6

1.3

1025.22

366.46

titre

20.07

487

291

(3015171) Extractable nuclear Ab [Units/volume] in Serum

443

404

15.62

307.65

1.9

1.2

3.05

0.93

u/ml

1.17

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

350

214

21.51

307.65

1.9

1.1

56.31

19.03

u/ml

2.65

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

619

317

34.36

307.65

7.3

1.3

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

179

29.62

263.56

1.7

1.1

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

179

29.62

263.56

1.7

1.1

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

179

29.62

263.56

1.7

1.1

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

179

29.20

262.22

1.7

1.1

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

179

29.20

262.22

1.7

1.1

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

179

29.20

262.22

1.7

1.1

—

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

232

182

15.10

246.78

1.6

1.2

5.29

4.94

u/ml

0.08

145

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

228

186

14.46

236.76

1.6

1.2

8.33

3.36

u/ml

1.43

136

(3005719) IgG [Mass/volume] in Serum or Plasma

426

788

7.35

235.06

4.0

2.6

11.33

10.35

g/l

3.22

408

716

(40760892) CBC W Ordered Manual Differential panel - Blood

1150

5348

7.62

220.93

15.9

5.8

—

(46235689) Lupus anticoagulant aPTT, dRVVT and PT screening panel W Reflex

181

123

16.77

207.64

2.9

2.3

—

(3001604) Monocytes [#/volume] in Blood

1166

5695

7.45

205.25

15.7

5.3

0.55

e9/l

0.00

1110

4948

(3006315) Basophils [#/volume] in Blood

1166

5708

7.42

204.29

15.7

5.3

0.04

e9/l

5.00

1110

4950

(3022096) Basophils/100 leukocytes in Blood

1097

5165

6.30

198.91

16.1

5.4

0.66

0.69

0.89

1072

4805

(3013115) Eosinophils [#/volume] in Blood

1176

5922

7.35

195.58

16.2

5.6

0.15

0.18

e9/l

15.74

1123

5214

(3006504) Eosinophils/100 leukocytes in Blood

1107

5340

6.24

192.22

16.2

5.4

2.47

2.79

4.84

1079

4985

(3019198) Lymphocytes [#/volume] in Blood

1166

5879

7.06

192.00

15.8

5.3

1.65

1.94

e9/l

11.79

1119

5238

(3019069) Monocytes/100 leukocytes in Blood

1109

5376

6.23

190.85

16.8

5.7

9.21

8.31

15.68

1079

5026

(3004616) Nuclear Ab [Presence] in Serum

166

114

16.40

189.04

1.9

1.1

—

(3018010) Neutrophils/100 leukocytes in Blood

1114

5479

6.17

186.57

15.6

5.2

58.48

56.53

6.01

1083

5132

(3002030) Lymphocytes/100 leukocytes in Blood

1116

5548

6.10

182.91

16.4

5.4

26.88

28.80

7.37

1086

5207

(3013650) Neutrophils [#/volume] in Blood by Automated count

1208

6697

7.08

165.75

18.8

8.5

3.76

3.97

e9/l

3.00

1148

5866

(3028026) IgM [Mass/volume] in Serum or Plasma

314

622

6.23

157.51

2.0

1.8

1.32

1.36

g/l

0.13

289

571

(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum

126

18.62

154.83

1.7

1.1

55.48

—

u/ml

—

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

206

292

8.11

141.51

1.6

1.5

703.00

110.00

titre

—

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

936

4917

3.76

119.73

3.4

2.3

81.52

77.32

nmol/l

4.58

897

4432

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

373

1069

4.40

118.69

3.6

4.3

244.60

250.01

u/l

0.24

360

1020

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

697

3125

3.46

113.07

3.1

2.0

181.71

189.58

u/l

0.06

670

2938

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

207

399

5.92

104.93

2.4

1.8

1.55

1.52

g/l

0.13

186

344

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

15.38

102.30

1.3

1.2

—

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

950

5387

3.40

100.06

10.6

6.1

1.22

mmol/l

1.32

833

4580

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

14.17

99.75

1.3

1.1

1.12

1.05

ratio

1.17

(3002179) Metamyelocytes/100 leukocytes in Blood

303

838

4.34

99.74

5.9

3.5

0.41

0.83

3.60

138

249

(3004588) Protein electrophoresis panel - Serum or Plasma

259

644

4.71

97.65

1.9

2.5

—

(3020630) Protein [Mass/volume] in Serum or Plasma

286

772

4.40

97.04

2.0

2.9

66.12

66.96

g/l

0.91

267

709

(3017181) Myelocytes/100 leukocytes in Blood

316

920

4.15

96.84

6.6

3.6

0.62

1.13

3.93

141

293

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

179

327

6.13

95.70

1.6

1.5

0.10

0.07

iu/ml

0.19

(3000850) Epithelial cells [#/volume] in Urine

531

2193

3.30

95.29

4.7

2.4

4.64

7.77

e6/l

5.77

497

1962

(3037467) Urinalysis macro (dipstick) panel - Urine

1191

7936

4.47

94.18

11.2

4.1

—

(3018095) Leukocytes [#/volume] in Urine

756

3853

3.11

93.76

7.9

3.4

78.82

97.30

e6/l

0.34

586

2607

(3013707) Erythrocyte sedimentation rate by Westergren method

1245

8609

5.22

92.36

13.0

3.7

15.66

11.70

mm/h

18.03

1211

7966

(3025159) Blasts/100 leukocytes in Blood

289

815

4.21

92.19

6.7

3.7

0.38

0.55

0.12

112

193

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

129

173

8.12

92.03

5.6

287.59

163.95

iu/ml

0.89

(3002582) Erythrocytes [#/volume] in Urine

665

3182

3.09

91.79

6.3

2.9

104.28

88.22

e6/l

0.07

566

2399

(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum

14.96

90.99

1.5

1.1

59.72

9.50

u/ml

—

(3021440) Promyelocytes/100 leukocytes in Blood

298

869

4.09

90.70

6.8

3.7

0.01

0.14

5.66

123

241

(3009261) Glucose [Presence] in Urine by Test strip

963

5761

3.18

87.34

6.9

3.5

0.00

0.01

estimate

0.80

210

1021

(3035350) Ketones [Presence] in Urine by Test strip

954

5688

3.15

86.82

6.8

3.5

0.00

estimate

0.99

221

1117

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

384

1367

3.50

86.65

3.6

2.3

21.17

22.56

1.26

345

1173

(3021601) Nitrite [Presence] in Urine by Test strip

955

5710

3.14

86.22

9.4

4.7

0.00

estimate

0.50

212

1051

(3004789) Transferrin [Mass/volume] in Serum or Plasma

401

1472

3.42

86.11

3.5

2.2

2.21

2.39

g/l

8.23

387

1361

(3030467) Casts [#/volume] in Urine by Automated count

615

2908

3.00

85.25

6.4

2.8

0.26

0.44

e6/l

1.67

520

2171

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

1243

8805

4.85

83.74

16.1

6.9

73.98

77.02

u/l

1.30

1224

8271

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

20.01

83.67

1.2

1.1

—

(3015736) pH of Urine

822

4592

2.93

82.81

5.4

3.2

5.99

5.88

0.44

374

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

856

4890

2.95

82.62

8.6

5.4

1.22

mmol/l

1.06

809

4446

(3022948) Iron [Moles/volume] in Serum or Plasma

419

1629

3.25

81.32

3.5

2.2

11.70

13.33

umol/l

5.17

406

1511

(3024561) Albumin [Mass/volume] in Serum or Plasma

830

4707

2.89

80.44

7.4

4.4

34.55

36.09

g/l

12.74

781

4390

(3023368) Bacteria identified in Blood by Culture

561

2610

2.93

78.82

6.1

4.0

—

(36304419) Bacteria [Presence] in Urine

593

2877

2.85

76.52

6.2

2.7

—

(3007164) IgA [Mass/volume] in Serum or Plasma

521

2384

2.89

74.75

1.9

1.4

2.42

2.28

g/l

1.20

360

1435

(40768446) Kidney Pathology biopsy report

21.57

74.56

1.3

1.5

—

(3020779) Urea [Moles/volume] in Serum or Plasma

259

779

3.86

74.52

10.6

6.8

9.72

8.77

mmol/l

1.32

251

744

(3011412) CD3 cells [#/volume] in Blood

10.57

74.07

2.5

2.6

0.88

1.12

e9/l

1.50

(3027945) Reticulocytes/100 erythrocytes in Blood

314

1077

3.47

74.05

3.8

2.6

1.77

1.84

0.46

291

961

(3023520) Reticulocytes [#/volume] in Blood

253

771

3.79

71.23

3.2

2.6

70.33

73.04

e9/l

0.46

170

584

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

160

344

5.13

71.02

1.8

2.1

3.16

2.89

g/l

2.10

149

317

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

165

365

4.99

70.83

1.7

2.1

3.50

3.56

g/l

0.20

154

339

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

165

366

4.98

70.60

1.7

2.1

7.22

7.41

g/l

0.68

154

339

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

165

366

4.98

70.60

1.7

2.1

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

127

224

6.14

69.90

1.4

1.5

—

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

155

337

5.05

67.83

1.7

2.1

11.62

10.12

g/l

2.95

144

309

(3011397) Hemoglobin [Presence] in Urine by Test strip

541

2637

2.72

67.38

5.6

3.5

—

(3034426) Prothrombin time (PT)

15.88

66.86

1.4

1.2

—

(3003458) Phosphate [Moles/volume] in Serum or Plasma

343

1318

3.13

66.41

9.5

5.0

1.09

1.04

mmol/l

2.35

325

1220

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

138

276

5.44

66.39

1.8

1.9

0.00

0.02

g/l

0.51

129

258

(3013293) Extractable nuclear Ab [Presence] in Serum

122.75

65.49

2.0

1.5

—

(3026782) Osmolality of Urine

461

2099

2.79

65.27

5.8

2.6

507.57

524.98

mosm/kgh2o

1.12

419

1801

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

552

2755

2.66

65.11

3.5

2.8

1307.73

1008.07

ng/l

0.97

492

2286

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

146

315

5.06

64.39

1.8

2.3

0.36

0.97

g/l

1.42

134

280

(3018418) pH of Serum or Plasma

610

3212

2.60

64.24

6.3

3.6

7.39

7.40

0.78

112

598

(40768443) Skin Pathology biopsy report

180

470

4.25

62.53

1.3

1.2

—

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

134

283

5.13

60.50

1.8

1.9

35.56

38.34

g/l

4.19

123

256

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

128

260

5.32

60.42

1.8

1.9

0.00

g/l

-0.00

120

244

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

127

259

5.30

59.66

1.8

1.9

0.00

g/l

-0.00

120

244

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

398

1757

2.77

58.98

4.9

2.4

1.00

1.19

e6/l

0.48

270

941

(3021589) Normoblasts [#/volume] in Blood

820

5115

2.47

57.97

18.7

8.5

0.00

e9/l

0.46

735

4191

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

447

2110

2.65

57.82

1.4

1.3

44.48

32.00

iu/ml

1.02

156

689

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

11.15

56.89

1.9

1.2

5.90

6.37

u/l

0.17

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

532

2771

2.49

55.53

2.9

2.1

3.00

2.92

mg/l

0.31

483

2361

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

428

2042

2.58

53.53

1.3

1.2

15.00

13.16

u/ml

0.18

179

806

(3017143) Hepatitis C virus Ab [Presence] in Serum

317

1305

2.85

53.06

1.6

1.5

—

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

10.22

51.88

2.3

—

(40758558) Short blood count panel - Blood

548

2978

2.39

51.15

12.1

6.3

—

(3034770) Mitochondria Ab [Titer] in Serum

123

278

4.76

51.10

1.4

1.2

1395.00

1048.18

titre

—

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

9.89

50.66

2.7

2.5

395.69

452.12

e6/l

0.34

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

102

198

5.48

50.50

1.3

1.5

—

(3024980) IgG subclass 4 [Mass/volume] in Serum

157

6.06

49.88

1.7

1.5

0.53

0.74

g/l

1.08

124

(3007566) Smooth muscle Ab [Titer] in Serum

120

273

4.72

49.43

1.3

1.2

214.00

89.52

titre

—

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

232

849

3.08

47.68

5.6

3.4

92.12

79.50

ng/l

1.52

215

748

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

176

5.59

47.30

1.3

1.5

134.50

113.62

u/ml

0.32

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

121

287

4.52

47.29

2.2

2.1

106.41

258.78

ug/l

4.33

110

265

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

13.25

47.02

1.4

1.1

—

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

13.25

47.02

1.3

1.1

—

(3042936) Bacteria identified in Isolate by Culture

332

1482

2.63

46.86

2.5

1.9

—

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

157

5.84

46.53

1.6

1.1

—

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

353

1640

2.54

45.74

5.5

2.6

2.42

3.57

e6/l

1.76

226

826

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

349

1614

2.55

45.65

2.4

1.7

—

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

158

475

3.62

44.51

1.6

2.0

39.40

39.60

u/l

0.04

141

425

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

858

5840

2.22

44.34

7.2

5.8

10.08

10.59

umol/l

0.62

822

5524

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

8.36

43.79

1.4

1.1

278.57

93.33

titre

—

(3036481) Cortisol [Moles/volume] in Serum or Plasma

266

1099

2.76

43.50

2.0

349.26

375.49

nmol/l

1.30

242

1009

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

187

5.20

43.20

1.3

353.15

267.60

u/ml

0.78

113

(3034860) Kappa light chains.free [Mass/volume] in Serum

113

274

4.40

42.88

1.9

3.9

50.15

67.67

mg/l

0.33

220

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

113

275

4.38

42.68

1.9

3.9

39.65

43.34

mg/l

0.12

221

(3022217) INR in Platelet poor plasma by Coagulation assay

727

4716

2.13

41.44

20.9

12.0

1.28

1.18

inr

2.15

226

1424

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

203

4.89

41.13

1.2

1.3

—

(3018677) aPTT in Platelet poor plasma by Coagulation assay

329

1563

2.45

40.04

2.9

2.0

30.61

29.34

2.09

321

1516

(3037121) Protein [Mass/volume] in Urine

127

354

3.85

39.87

4.8

3.1

0.36

0.30

g/l

0.31

131

(3020876) Protein [Mass/time] in 24 hour Urine

6.83

39.77

2.6

2.8

1.16

1.53

g/24h

0.47

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

108

268

4.28

39.73

1.8

3.8

1.32

1.87

ratio

—

(3031040) Bacteria [#/volume] in Urine by Automated count

1026

7681

2.28

39.51

6.7

4.3

1229.82

2002.82

e6/l

0.26

100

(3037756) Immunofixation for Serum or Plasma

202

4.81

39.45

1.2

1.7

—

(3021447) Carbon dioxide [Partial pressure] in Venous blood

223

891

2.79

38.60

4.9

3.4

5.80

5.82

kpa

0.14

213

867

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

105

269

4.14

37.00

2.7

2.8

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

209

831

2.78

36.40

1.3

1.4

—

(3002032) Base excess in Venous blood by calculation

218

887

2.73

36.31

4.9

3.4

1.87

1.93

mmol/l

0.08

182

743

(3009508) Creatinine [Moles/volume] in Urine

548

3316

2.08

36.23

6.1

3.0

6.99

7.19

mmol/l

0.47

487

2832

(3001122) Ferritin [Mass/volume] in Serum or Plasma

782

5383

2.03

36.06

4.0

2.7

160.16

93.44

ug/l

8.09

749

5010

(3000475) Leukocytes [#/volume] in Synovial fluid

235

4.31

35.91

1.8

1.7

17947.65

13018.23

e6/l

0.25

182

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

13.38

35.78

1.6

1.2

—

(3026008) Bacteria identified in Urine by Culture

582

3639

2.03

34.81

3.6

2.9

—

(3012095) Magnesium [Moles/volume] in Serum or Plasma

334

1688

2.29

34.74

3.9

3.3

0.82

mmol/l

0.02

317

1590

(3029075) Extractable nuclear Ab panel - Serum

11.17

33.87

1.6

1.0

—

(3012516) Albumin [Mass/volume] in Urine

508

3048

2.05

33.85

6.2

3.2

805.69

406.20

mg/l

0.75

364

1890

(3007853) Bacteria identified in Skin by Aerobe culture

270

1257

2.42

33.83

2.1

1.6

—

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

101

272

3.93

33.20

4.3

4.1

1.66

1.47

mg/l

1.23

252

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

12.05

32.60

3.0

2.9

—

(3020682) Albumin/Creatinine [Ratio] in Urine

523

3210

2.01

32.40

7.4

3.7

21.73

8.03

mg/mmol

3.24

382

1970

(3026493) Urate [Moles/volume] in Serum or Plasma

464

2734

2.05

32.18

3.8

2.5

4416.79

5329.30

umol/l

0.15

416

2401

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

358

1913

2.17

32.17

1.7

1.6

—

(3032035) Polymorphonuclear cells/100 leukocytes in Blood

220

4.20

32.00

5.4

3.6

59.49

58.46

0.28

220

(21494814) CD8 cells/100 lymphocytes in Specimen

11.63

31.88

2.1

2.2

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

102

5.89

31.80

3.4

—

(4062490) Immunoglobulin typing, IgG

5.96

31.65

1.5

1.4

—

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

116

355

3.47

31.58

2.1

2.0

1.45

1.82

ug/l

0.15

109

311

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

104

297

3.70

31.42

1.6

2.1

11.44

11.52

mg/l

0.04

276

(3030905) Polymorphonuclear cells [#/volume] in Blood

212

4.21

31.00

5.2

3.4

3.62

4.19

e9/l

1.76

212

(3019225) pH of Specimen

236

1079

2.43

30.56

7.2

3.7

—

(3000494) Fungus identified in Specimen by Culture

274

1342

2.30

30.30

1.7

1.4

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

8.51

30.09

1.3

1.5

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

8.51

30.09

1.3

1.5

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

269

3.76

29.80

1.6

1.4

—

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

178

722

2.68

29.56

2.1

1.6

—

(3024139) IgG subclass 3 [Mass/volume] in Serum

5.81

29.27

1.6

1.4

0.47

0.34

g/l

1.27

(3028192) IgG subclass 2 [Mass/volume] in Serum

5.81

29.27

1.6

1.4

2.69

2.65

g/l

0.04

(3027135) IgG subclass 1 [Mass/volume] in Serum

5.81

29.27

1.6

1.4

7.04

6.70

g/l

0.20

(3017732) Neutrophils [#/volume] in Blood

188

791

2.59

28.97

3.0

2.8

3.85

6.04

e9/l

1.75

136

668

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

158

609

2.80

28.94

5.6

3.4

5.12

5.14

kpa

0.14

153

590

(3045424) Erythrocytes [Presence] in Urine

175

4.41

28.91

2.1

1.4

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

112

359

3.31

28.30

1.2

1.3

—

(3010375) cycloSPORINE [Mass/volume] in Blood

9.63

28.03

29.6

32.5

101.68

121.63

ug/l

0.77

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

234

1105

2.34

28.01

2.2

1.7

—

(3000991) Gas panel - Venous blood

185

785

2.56

27.98

8.3

7.3

—

(3009343) pH of Capillary blood

155

603

2.77

27.86

5.5

3.4

7.42

7.41

0.77

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

6.79

27.31

2.3

2.8

41.42

42.09

0.06

(3022313) Gas panel - Capillary blood

127

449

3.01

27.19

5.9

3.6

—

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

175

737

2.57

26.84

4.0

2.7

203.14

172.57

ng/l

0.37

162

668

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

644

4432

1.84

26.80

2.2

1.9

98.88

96.73

pmol/l

0.56

356

2238

(3017817) Protein [Mass] in Urine collected for unspecified duration

6.14

26.50

2.7

2.4

—

(3015377) Calcium [Moles/volume] in Serum or Plasma

582

3893

1.85

26.45

3.9

3.3

2.33

2.36

mmol/l

5.50

521

3451

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

269

3.55

26.08

4.2

3.2

0.32

0.37

u/ml

0.81

152

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

103

331

3.28

25.90

4.2

2.6

193.07

178.17

0.89

316

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

231

1120

2.27

25.86

2.2

1.7

—

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

438

2691

1.92

25.85

2.5

1.7

1.53

1.01

mg/l

2.99

352

2041

(3019309) Folate [Moles/volume] in Red Blood Cells

336

1885

2.03

25.82

1.9

1.7

1125.30

1194.83

nmol/l

0.77

274

1433

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

457

2848

1.90

25.82

1.4

1.3

1.32

1.61

u/ml

0.20

106

752

(46235355) HIV 1 and 2 tests - Meaningful Use set

386

2274

1.97

25.81

1.8

—

(40760888) Immunoglobulin light chains.free panel - Serum

209

3.89

25.79

1.8

4.4

—

(3033658) Prothrombin time (PT) actual/Normal

446

2760

1.91

25.73

5.7

3.6

93.25

94.51

0.48

433

2688

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

147

581

2.71

25.57

5.5

3.4

1.35

1.80

mmol/l

0.59

118

436

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

181

793

2.47

25.49

2.6

2.4

44.27

28.22

au/ml

0.47

(3000093) Morphology [Interpretation] in Blood Narrative

5.69

25.02

1.1

1.2

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

108

366

3.11

24.85

2.5

1.7

—

(3048689) Calprotectin [Mass/mass] in Stool

281

1507

2.08

24.26

2.6

2.3

110.18

116.66

ug/g

0.15

237

1179

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

257

3.50

24.23

1.5

—

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

167

722

2.49

24.15

1.4

1.3

61.37

41.19

au/ml

—

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

5.71

24.07

1.4

1.2

—

titre

—

(3045414) Leukocytes [Presence] in Urine

131

504

2.77

23.97

2.4

1.8

—

(3029937) Albumin [Presence] in Urine by Test strip

470

3012

1.85

23.96

8.1

3.8

0.00

0.01

estimate

1.28

208

1034

(3024354) Oxygen [Partial pressure] in Venous blood

167

728

2.47

23.71

3.9

2.9

4.63

4.59

kpa

0.08

156

706

(3021788) Differential panel - Synovial fluid

178

3.97

23.22

1.6

1.7

—

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

113

411

2.90

22.95

2.6

1.8

—

(3021960) Folate [Moles/volume] in Serum or Plasma

402

2481

1.87

22.92

1.7

1.5

20.07

21.49

nmol/l

1.22

361

2122

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

6.42

22.34

1.1

1.2

—

(3036489) Thrombin time

114

425

2.83

22.12

3.7

2.1

21.99

21.01

0.67

101

373

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

1308

11701

2.95

22.03

32.2

12.0

18.55

21.31

mg/l

3.16

1191

9097

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

5.25

22.03

1.1

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

326

3.09

22.00

1.3

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

190

3.77

21.95

1.5

1.3

—

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

553

3796

1.76

21.93

4.2

3.0

32.14

30.67

u/l

0.52

530

3622

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

5.25

21.55

1.1

302.69

233.01

mg/l

0.97

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

572

3982

1.74

21.46

4.2

3.2

253.93

42.90

ng/l

0.75

405

2471

(36660697) Celiac disease serology panel - Serum

201

992

2.20

21.32

1.3

1.2

—

(3041096) Erythrocytes [Presence] in Urine by Automated

474

3136

1.78

21.20

6.7

3.1

—

(40768797) Stomach Pathology biopsy report

286

1615

1.97

21.12

1.3

1.2

—

(3035947) Staphylolysin Ab [Units/volume] in Serum

7.77

20.86

1.1

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

183

3.74

20.79

1.7

1.4

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

183

3.74

20.79

1.7

1.4

—

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

333

1991

1.88

20.67

5.0

3.4

443.18

289.57

ng/l

0.35

264

1405

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

615

4403

1.71

20.60

7.4

3.6

—

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

4.96

20.22

1.3

1.2

57.87

35.28

mg/l

1.23

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

508

3478

1.73

19.84

2.9

2.4

57.67

59.00

u/l

0.23

479

3198

(3019174) dRVVT (LA screen)

19.71

19.54

1.4

1.1

—

(3013826) Glucose [Moles/volume] in Serum or Plasma

827

6468

1.69

19.42

5.8

4.3

6.24

6.61

mmol/l

6.62

790

5994

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

115

4.38

19.34

1.5

1.6

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

15.82

19.31

1.2

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

15.82

19.31

1.2

1.1

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

15.82

19.31

1.2

1.1

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

15.82

19.31

1.2

1.1

—

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

250

3.20

19.02

1.5

—

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

128

549

2.47

18.72

2.0

1.6

—

(3044009) aPTT.lupus sensitive (LA screen)

19.02

18.67

1.6

1.2

—

(3052851) Hemolysis interference index of Serum or Plasma

308

2.95

18.53

3.8

3.1

—

(3028433) Virus identified in Specimen by Culture

7.55

18.27

1.3

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

180

3.56

18.27

1.5

1.6

—

(3042891) Cardiolipin IgM Ab [Mass/volume] in Serum

15.84

17.52

1.1

—

(3044640) Blood type and Crossmatch panel - Blood

513

3617

1.66

17.40

2.9

2.2

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

207

3.30

17.26

1.1

1.2

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

192

3.39

17.24

1.5

1.3

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

192

3.39

17.24

1.5

1.3

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

327

2.81

17.16

1.4

1.3

—

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

191

1002

2.05

17.12

2.4

2.2

0.20

0.22

g/l

2.62

176

944

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

409

2740

1.70

16.73

2.8

2.1

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

7.38

16.56

2.2

2.5

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

5.26

15.84

1.1

—

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

267

2.91

15.83

1.6

1.2

—

(40761535) Cells panel - Urine sediment

168

866

2.07

15.74

7.3

3.3

—

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

4.83

15.70

1.7

1.5

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

104

4.13

15.49

1.6

—

(3044290) Cell count panel - Cerebral spinal fluid

234

3.00

15.25

1.3

1.5

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

110

4.00

15.19

1.1

1.2

—

(3044941) Cell count panel - Synovial fluid

158

3.45

15.03

1.6

1.5

—

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

123

3.75

14.51

1.8

1.6

57.48

58.96

0.08

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

5.27

14.41

1.6

1.7

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

5.27

14.41

1.6

1.7

—

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

217

1258

1.86

14.39

2.7

6.78

7.04

umol/l

0.09

192

1067

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

189

3.16

14.28

1.4

1.3

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

107

3.92

14.11

1.4

1.6

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

322

2.61

13.88

1.2

1.1

—

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

113

3.80

13.86

1.0

1.3

—

(3044927) Protein electrophoresis panel - Urine

4.15

13.79

1.1

1.2

—

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

10.58

13.75

2.0

2.4

—

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

4.48

13.59

1.9

1.5

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

190

3.09

13.52

1.3

1.1

—

(3039744) RNA polymerase III Ab [Units/volume] in Serum

34.39

13.51

1.1

1.2

—

(3023199) Leukocytes [#/volume] in Pleural fluid

4.33

13.41

1.5

1.3

4306.57

1628.13

e6/l

0.96

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

141

3.41

13.22

1.3

1.4

—

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

277

2.69

13.17

1.5

1.6

—

(3013512) EKG study

440

3153

1.58

13.15

4.4

3.4

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

12.29

13.11

1.2

1.3

—

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

138

3.41

12.94

1.4

1.1

83.20

96.82

1.92

129

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

5.40

12.79

1.1

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

125

3.52

12.69

2.1

2.6

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

150

3.28

12.67

1.3

1.1

—

(3012441) Differential panel - Pleural fluid

4.44

12.66

1.5

1.4

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

4.82

12.63

1.2

1.0

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

187

3.02

12.62

1.6

—

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

183

3.03

12.47

1.3

1.1

115.02

118.56

0.26

169

(3019150) Specific gravity of Urine by Refractometry

358

2470

1.60

12.46

6.9

3.9

1.01

1.02

kg/l

0.67

354

(3042111) Morphology [Interpretation] in Bone marrow Narrative

159

3.16

12.18

1.4

1.5

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

115

3.55

12.02

1.1

—

(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid

131

3.36

11.83

1.1

—

(3005322) IgE [Units/volume] in Serum or Plasma

151

828

1.92

11.80

1.3

1.2

136.33

181.29

u/ml

0.48

136

759

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

4.40

11.72

1.1

1.2

—

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

4.80

11.68

1.4

1.2

—

(3016018) Differential panel - Cerebral spinal fluid

108

3.59

11.62

1.3

1.6

—

(3028308) Erythrocytes [#/volume] in Pleural fluid

4.24

11.56

1.4

1.3

52865.38

139668.22

e6/l

0.37

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

8.70

11.53

1.4

8.46

8.85

ug/l

0.13

(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum

5.44

11.37

2.4

1.8

75.82

76.47

ug/l

0.01

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

147

809

1.91

11.36

2.4

2.2

6.38

ug/l

0.00

124

713

(40768806) Pleura Pathology biopsy report

3.97

11.32

1.4

1.6

—

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

156

878

1.87

11.25

5.0

3.4

1.22

1.23

mmol/l

0.91

146

744

(3000570) Elastase.pancreatic [Mass/mass] in Stool

331

2.40

11.22

1.4

332.74

301.44

ug/g

0.62

192

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

301

2053

1.59

10.80

2.9

2.7

2.45

mmol/l

0.19

270

1812

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

3.60

10.79

1.2

1.1

—

(3014576) Chloride [Moles/volume] in Serum or Plasma

198

1215

1.73

10.70

7.4

6.0

104.13

104.23

mmol/l

0.10

198

1215

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

100

3.56

10.63

1.3

1.9

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

189

2.82

10.63

1.3

1.2

—

(3010144) Erythrocytes [#/volume] in Synovial fluid

3.61

10.51

1.6

1.3

203118.00

153295.19

e6/l

0.09

(4035726) Immunohistochemistry procedure

168

993

1.79

10.33

1.4

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

4.32

10.32

1.4

1.2

—

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

4.45

10.28

1.2

1.0

—

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

4.45

10.28

1.2

1.0

—

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

187

2.79

10.27

1.2

—

(3017704) Immunofixation for Urine

4.59

10.26

1.0

1.7

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

4.76

10.26

1.3

2.1

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

138

3.11

10.26

1.2

1.3

—

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

1209

11070

1.70

10.11

24.5

11.2

83.09

83.61

ml/min/173m2

0.31

1091

9056

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

115

608

1.97

9.99

1.8

1.5

—

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

673

5486

1.44

9.96

3.4

2.5

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

191

2.73

9.88

1.2

1.1

—

(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma

4.94

9.80

1.0

1.1

254.32

193.38

iu/ml

0.24

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

252

2.49

9.71

1.4

1.5

1261.94

452.33

e6/l

0.36

207

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

252

2.49

9.71

1.3

1.5

17.30

9.60

e6/l

0.48

194

(3023419) Bacteria identified in Sputum by Culture

144

2.98

9.56

2.7

3.3

—

(3021901) Oxygen saturation in Capillary blood

161

2.85

9.49

2.4

2.5

—

(3000060) B lymphocytes [#/volume] in Blood

8.10

9.35

1.7

2.2

161.43

174.29

e6/l

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

4.72

9.31

1.5

1.8

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

4.72

9.31

1.5

1.8

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

4.72

9.31

1.5

1.8

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

141

2.97

9.29

1.1

1.2

—

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

152

2.89

9.28

1.1

—

(3042733) HLA Ab [Presence] in Serum

9.10

9.03

5.8

3.0

—

(44817194) Complement alternate pathway AH50 actual/normal in Serum by Immunoassay

9.10

9.03

1.1

84.17

106.25

1.39

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

166

2.77

8.99

1.3

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

243

2.45

8.98

1.6

1.4

—

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

145

2.88

8.85

1.5

1.4

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

4.70

8.83

1.1

1.2

—

(40768804) Tissue Pathology biopsy report

604

4904

1.41

8.76

2.3

2.0

—

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

3.60

8.70

1.1

1.01

1.08

u/l

—

(40768441) Liver Pathology biopsy report

3.60

8.70

1.3

1.4

—

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

4.80

8.60

1.1

518.14

48.78

ng/l

—

(3019550) Sodium [Moles/volume] in Serum or Plasma

1273

11922

1.79

8.55

26.7

13.7

139.14

139.66

mmol/l

9.67

1256

11605

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

101

3.22

8.39

1.5

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

101

3.22

8.39

1.5

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

101

3.22

8.39

1.5

—

(3045788) Cell count panel - Pleural fluid

3.78

8.36

1.4

1.3

—

(40763470) Parainfluenza virus 4 RNA [Presence] in Isolate by NAA with probe detection

128

2.94

8.32

1.7

1.3

—

(40763324) Parainfluenza virus 1 RNA [Presence] in Isolate by NAA with probe detection

128

2.94

8.32

1.7

1.3

—

(3023103) Potassium [Moles/volume] in Serum or Plasma

1274

11956

1.77

8.19

27.3

13.7

3.93

3.94

mmol/l

0.96

1254

11618

(3024891) Influenza virus A+B Ag [Presence] in Specimen

308

2.20

8.01

1.3

1.2

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

4.17

8.01

1.9

1.3

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

4.17

8.01

1.9

1.3

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

3.74

7.92

1.3

1.1

—

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

10.86

7.80

1.9

1.4

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

106

3.07

7.76

2.5

3.7

—

(3010838) Calcium [Moles/time] in 24 hour Urine

230

2.36

7.64

1.7

2.0

4.31

4.92

mmol/24h

0.69

200

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

1060

9606

1.43

7.41

4.7

4.3

14.72

14.63

pmol/l

0.57

988

8818

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

203

2.41

7.33

5.6

2.5

—

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

15.83

7.23

2.5

4.9

—

(3022145) Colonoscopy Study observation

191

1280

1.57

7.21

1.4

1.3

—

(3009871) Measles virus Ab [Titer] in Serum

4.52

7.19

1.9

1.6

—

(3042631) Mycobacterium sp identified in Specimen

128

2.78

7.16

2.7

2.6

—

(3006184) Hemoglobin [Mass/volume] in Capillary blood

207

2.37

7.04

1.7

2.3

130.25

130.89

g/l

0.06

157

(3037692) Legionella sp identified in Specimen by Organism specific culture

5.87

6.92

1.6

1.3

—

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

9.36

6.79

1.0

4.6

—

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

165

1084

1.59

6.78

7.2

7.6

4.83

5.06

kpa

2.50

156

1041

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

144

2.61

6.73

1.8

1.4

—

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

1308

12461

1.82

6.72

24.4

9.6

25.24

24.92

u/l

0.30

1295

12039

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

161

1054

1.60

6.71

2.8

2.2

39.75

40.96

u/l

0.08

138

885

(21494890) Protein electrophoresis panel - 24 hour Urine

3.02

6.67

1.4

2.3

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

6.46

6.64

1.1

—

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

140

889

1.64

6.61

3.6

2.3

60.69

68.98

ml/min/173m2

1.69

354

(3016502) Oxygen saturation in Arterial blood

148

953

1.62

6.61

7.0

8.2

94.74

96.01

0.87

143

924

(3027801) Oxygen [Partial pressure] in Arterial blood

164

1084

1.58

6.57

7.3

7.6

11.28

12.68

kpa

4.08

156

1043

(3024522) Salmonella sp identified in Specimen by Organism specific culture

146

2.58

6.56

1.8

1.4

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

4.19

6.56

1.9

1.3

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

4.19

6.56

1.9

1.3

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

147

2.56

6.47

1.8

1.4

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

7.43

6.41

1.0

1.1

—

(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence

3.37

6.29

1.1

1.4

—

300.00

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

198

1380

1.51

6.24

4.6

4.3

34.33

32.53

1.48

153

945

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

6.31

6.17

1.1

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

5.77

6.15

1.1

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

322

2.00

6.10

1.2

—

(3025941) Bacteria identified in Stool by Culture

110

672

1.69

6.03

1.3

1.2

—

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

2.96

6.02

2.0

1.5

24.30

36.49

0.96

(1761868) Lipid panel - Serum or Plasma

343

4313

0.73

5.96

2.6

2.7

—

(3024928) Oxygen saturation in Venous blood

199

2.25

5.83

5.2

2.8

—

(3023410) Appearance of Cerebral spinal fluid

120

2.62

5.74

1.4

1.7

—

(3003396) Base excess in Arterial blood by calculation

160

1085

1.54

5.72

7.2

7.6

0.69

1.11

mmol/l

0.57

129

873

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

129

834

1.60

5.68

2.6

3.2

4.15

4.51

pmol/l

4.29

114

731

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

171

2.32

5.57

1.0

—

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

8.52

5.56

1.8

1.6

—

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

6.55

5.56

1.2

1.1

1.35

56.89

ug/l

—

(3024932) HLA-DR beta [Type]

5.40

5.54

1.0

1.1

—

(3000034) Microalbumin [Mass/volume] in Urine

2.80

5.48

4.5

2.6

89.42

12.87

mg/l

0.87

(3016650) Hepatitis A virus Ab [Presence] in Serum

173

2.29

5.43

1.0

1.1

—

(3024471) HLA-A [Type]

5.22

5.39

1.0

—

(3013247) Albumin in CSF/Albumin in Serum or Plasma

6.24

5.39

1.1

1.0

8.72

5.92

mg/g

0.60

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

7.91

5.34

1.1

1.0

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

143

2.41

5.33

1.9

1.4

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

143

2.41

5.33

1.9

1.4

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

144

2.40

5.25

1.9

1.4

—

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

348

1.88

5.22

1.1

0.78

5.43

u/ml

—

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

3.67

5.21

1.1

92.14

93.39

—

(3017569) Oxygen content in Arterial blood

3.78

5.09

3.6

—

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

493

1.73

5.07

9.4

10.8

—

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

153

1055

1.51

5.07

3.1

4.0

9.52

14.86

ug/l

0.43

115

831

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

5.04

4.94

1.1

1.2

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

3.51

4.90

1.1

1.0

—

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

3.51

4.90

1.1

90.71

88.42

—

(3036782) Glucose [Moles/volume] in Pleural fluid

2.80

4.89

1.5

1.2

7.33

6.64

mmol/l

0.44

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

4.58

4.87

1.1

1.4

—

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

867

7823

1.29

4.85

3.9

3.0

58.64

42.43

u/l

2.53

824

7320

(3001964) Herpes simplex virus Ag [Presence] in Specimen

4.25

4.82

1.8

1.2

—

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

11.48

4.78

20.1

12.3

4.79

8.27

mmol/l

—

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

9.05

4.78

1.2

1.1

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

2.70

4.76

4.7

2.1

—

(3024263) Appearance of Synovial fluid

3.30

4.75

1.4

1.5

—

(3003327) Ova and parasites identified in Stool by Light microscopy

405

1.77

4.70

2.3

1.7

—

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

1183

11167

1.40

4.68

5.8

5.0

1.91

1.97

mu/l

0.23

1123

10313

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

2.87

4.66

1.1

1.2

—

(3011648) Oxygen content in Venous blood

2.78

4.62

3.6

1.8

11.07

10.58

0.23

(3006442) Creatine [Moles/volume] in Serum or Plasma

2.70

4.59

1.5

1.3

78.96

74.74

umol/l

0.26

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

10.05

4.52

1.5

1.0

—

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

4.85

4.50

1.1

1.6

—

(3008037) Lactate [Moles/volume] in Venous blood

215

2.03

4.50

2.7

1.13

1.53

mmol/l

5.71

209

(3027456) Digoxin [Moles/volume] in Serum or Plasma

168

2.17

4.49

3.4

3.1

0.79

0.77

nmol/l

0.11

135

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

558

1.64

4.47

2.4

2.3

—

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

6.71

4.47

1.2

1.3

—

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

137

2.29

4.40

3.0

2.2

34.23

26.91

mg/l

0.23

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

294

2331

1.33

4.37

1.6

1.7

75889768.08

30149382.14

pmol/l

0.38

253

1947

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

3.12

4.37

1.2

1.3

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

2.90

4.34

1.2

1.3

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

348

1.79

4.32

1.3

1.2

—

(21494434) Karyotype in Bone marrow

2.55

4.31

1.1

1.2

—

(3000012) Reticulocyte production index

132

2.30

4.31

2.7

2.1

—

(3044889) 12 lead EKG panel

879

8002

1.27

4.29

4.2

3.4

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

3.06

4.25

1.2

1.3

—

(3022621) pH of Urine by Test strip

113

760

1.53

4.23

4.2

2.8

—

(3045142) Bone marrow Pathology biopsy report

115

2.37

4.17

1.1

1.3

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

2.68

4.16

1.1

1.5

—

(3001019) Free T4 and TSH panel - Serum or Plasma

784

0.53

4.09

1.4

1.7

—

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

5.03

4.00

1.1

1.2

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

349

1.75

4.00

1.3

1.2

—

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

2.66

3.90

1.1

0.36

0.97

nmol/l

—

(3025130) Human papilloma virus identified in Specimen

206

1.97

3.89

1.8

—

(40768795) Lymph node Pathology biopsy report

113

2.33

3.86

1.3

1.1

—

(3003181) Sodium [Moles/volume] in Urine

187

2.01

3.80

1.3

1.4

48.97

62.95

mmol/l

1.25

154

(1616796) Gas panel - Central venous blood

208

1.95

3.80

4.2

3.4

—

(3038515) Glucose [Moles/volume] in Venous blood

201

1.97

3.80

2.9

6.50

7.40

mmol/l

2.05

196

(3008898) HLA-B27 [Presence]

456

1.63

3.76

1.0

—

(3019768) Coxiella burnetii Ab [Presence] in Serum

12.04

3.76

1.0

—

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

12.04

3.76

1.0

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

2.42

3.73

1.2

1.1

—

(4200892) Spirometry reversibility

116

808

1.48

3.70

1.6

1.4

—

(3026389) Candida sp identified in Specimen by Organism specific culture

155

2.09

3.69

1.6

1.3

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

2.71

3.66

1.2

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

104

2.33

3.60

1.1

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

870

7988

1.24

3.59

3.8

3.2

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

2.83

3.53

1.1

1.3

—

(42529406) Shigella sp [Presence] in Stool by Culture

355

1.69

3.52

1.3

1.2

—

(3008536) Aspergillus sp Ab [Presence] in Serum

5.32

3.51

1.1

2.2

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

4.57

3.43

1.1

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

3.11

3.37

1.1

1.2

—

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

5.03

3.37

2.1

1.6

—

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

5.74

3.34

1.1

1.4

—

(40767503) Oxygen content in Capillary blood by calculation

191

1.91

3.26

2.5

2.4

16.63

16.52

0.06

(3002621) Streptococcal DNAse B [Units/volume] in Serum

8.60

3.26

1.0

1.1

—

(3035880) pH of Pleural fluid

3.04

3.25

1.1

—

(3014271) Vancomycin [Susceptibility]

3.04

3.25

3.8

2.4

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

1127

0.66

3.22

1.5

1.7

—

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

3.35

3.22

1.5

2.0

—

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

221

1.83

3.21

1.3

1.4

23.64

25.35

u/l

0.10

186

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

365

1.64

3.20

3.4

3.2

776.85

596.09

u/ml

0.09

317

(40761536) Microorganisms panel - Urine sediment

135

995

1.40

3.20

9.8

3.6

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

4.19

3.19

1.3

1.1

—

(3040151) Glucose [Moles/volume] in Capillary blood

2.26

3.13

2.7

8.5

6.62

7.03

mmol/l

0.27

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

2.30

3.11

1.0

—

(3000492) Spirometry study

154

1166

1.36

3.10

1.8

1.4

—

(3014051) Protein [Presence] in Urine by Test strip

300

1.69

3.05

3.4

2.3

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

3.35

3.02

1.2

—

(3010421) pH of Blood

264

1.73

2.98

4.2

3.4

7.41

7.42

0.27

235

(3003101) Alpha 1 antitrypsin [Mass/mass] in Stool

10.03

2.98

1.0

2.4

279.00

144.20

ug/g

—

(36305075) Vedolizumab [Mass/volume] in Serum or Plasma by Immunoassay

10.03

2.98

8.0

2.6

25.92

22.60

mg/l

—

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

4.73

2.92

2.0

1.0

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

3.46

2.90

1.1

—

(3035320) C reactive protein [Mass/volume] in Body fluid

2.39

2.90

2.7

2.1

—

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

6.69

2.87

1.2

—

(3019060) Gas panel - Arterial blood

630

1.46

2.85

3.7

6.1

—

(3051593) INR in Capillary blood by Coagulation assay

3.18

2.85

3.6

10.9

—

(21494755) Public health laboratory ask at order entry panel

1235

0.69

2.83

1.2

1.3

—

(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma

2.78

2.82

1.2

1.1

124.54

111.54

0.93

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

3.35

2.81

1.1

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

2.56

2.79

2.1

1.6

—

(40757373) Influenza virus identified in Isolate

3.93

2.77

2.0

1.4

—

(3026480) Teichoate Ab [Titer] in Serum

8.36

2.75

1.0

—

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

8.36

2.75

1.4

1.2

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

189

1.82

2.72

1.2

1.1

3.81

2.26

u/ml

—

(3004446) Plasmodium sp identified in Blood by Light microscopy

6.02

2.70

2.2

2.6

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

3.16

2.64

1.2

1.1

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

3.16

2.64

1.2

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

2.17

2.61

1.7

1.6

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

2.27

2.61

1.5

1.3

—

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

1109

10581

1.24

2.61

5.9

5.3

38.30

39.26

mmol/mol

1.97

1053

9822

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

702

1.41

2.59

1.0

—

(3050794) Legionella sp Ab [Presence] in Serum

7.16

2.55

1.0

1.1

—

(3030313) Adrenal Ab [Titer] in Serum

7.16

2.55

1.0

—

(3032352) Blasts [#/volume] in Cerebral spinal fluid

5.47

2.54

1.0

2.5

—

(3044242) Glucose [Moles/volume] in Arterial blood

2.62

2.53

4.0

3.2

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

2.52

2.53

1.1

1366.61

1631.86

miu/ml

0.43

(3036670) Protein [Mass/volume] in Synovial fluid

3.24

2.52

1.1

1.3

31.32

37.18

g/l

—

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

4.39

2.47

1.1

—

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

173

1.81

2.47

1.1

1.2

125.97

20.58

u/l

1.08

150

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

714

0.63

2.46

1.5

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

432

1.50

2.46

1.2

1.3

233.14

233.33

miu/ml

0.00

210

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

5.02

2.40

1.2

1.3

—

(40765096) Chromosome analysis panel by Banding

3.35

2.39

1.1

1.0

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

141

1099

1.31

2.38

3.9

3.0

—

(3000330) Specific gravity of Urine by Test strip

544

1.44

2.37

6.8

3.1

—

(3032057) Clostridioides difficile [Presence] in Stool

3.65

2.36

1.9

2.1

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

4.13

2.36

1.1

—

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

4.13

2.36

1.3

—

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

357

3103

1.20

2.32

1.7

1.33

1.34

mmol/l

0.14

320

2636

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

290

2471

1.22

2.31

1.6

1.5

—

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

2.39

2.29

1.0

1.1

20.00

27.11

u/l

0.42

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

137

1.84

2.14

1.0

1.1

—

(3032773) Endomysium IgG Ab [Titer] in Serum

123

1.88

2.12

1.0

1.1

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

2.15

2.09

1.0

—

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

2.27

2.08

1.6

1.7

1.67

2.32

u/field

—

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

5.01

2.07

1.2

—

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

5.01

2.07

1.2

1.1

—

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

5.01

2.07

1.2

1.4

—

(3012501) Base excess in Blood by calculation

215

1.64

2.04

4.9

3.6

2.92

2.86

mmol/l

0.04

145

(1761482) Bacteria [#/volume] in Urine by Culture

266

1.56

1.94

5.6

4.1

—

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

3.76

1.93

1.0

1.1

—

(3034891) Synovial lining cells/100 cells in Synovial fluid

2.32

1.88

1.8

1.4

4.60

5.45

—

(3051611) Lipemic interference index of Serum or Plasma

107

1.88

1.86

5.5

2.8

—

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

3.54

1.84

1.0

1.1

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

238

1.57

1.83

2.4

2.2

86.95

101.95

ug/min

0.13

143

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

782

0.70

1.82

1.3

1.4

—

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

4.18

1.82

1.2

1.6

—

(3049717) Cytology report of Urine Cyto stain

303

1.50

1.82

2.3

2.5

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

389

0.58

1.81

1.5

1.4

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

215

1.60

1.80

1.7

1.2

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

388

0.59

1.80

1.5

1.4

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

424

0.61

1.78

1.5

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

386

0.59

1.77

1.5

1.4

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

386

0.59

1.77

1.5

1.4

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

2.51

1.74

3.3

4.9

—

(3051651) Icteric interference index of Serum or Plasma

2.14

1.71

7.1

3.1

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

1.92

1.70

1.6

2.3

2.71

2.88

u/field

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

120

963

1.27

1.68

1.3

1.2

90.30

149.04

iu/ml

1.37

376

(3043238) Trisomy 21 risk [Likelihood] in Fetus

328

0.57

1.64

1.6

1.5

—

(3006462) Nitrate [Presence] in Urine

2.25

1.63

5.8

2.7

—

(3028772) Osteocalcin [Mass/volume] in Serum or Plasma

2.15

1.61

2.9

2.7

36991.67

36950.86

ug/l

0.00

(3029396) Erythrocyte agglutination [Presence] in Blood

2.51

1.60

1.6

3.4

—

(3047189) Immunofixation for 24 hour Urine

2.28

1.55

1.1

1.6

—

(3050129) First trimester maternal screen panel - Serum or Plasma

468

0.65

1.55

1.4

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

317

0.59

1.47

1.6

1.4

—

(3005532) Lymphocytes/100 leukocytes in Pleural fluid

2.51

1.45

1.3

1.2

40.43

57.67

—

(3005033) Fetal Nuchal fold Thickness US

314

0.60

1.42

1.6

1.4

—

(44786774) Adalimumab [Mass/volume] in Serum or Plasma

2.42

1.39

1.3

2.6

5.69

9.90

mg/l

—

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

150

1.61

1.38

1.4

1.3

—

nmol/l

—

(3022689) Creatine [Moles/volume] in Urine

2.62

1.37

3.5

1.4

—

(3048879) Bone marrow aspiration report

2.62

1.37

1.2

2.8

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

232

1.48

1.35

5.7

3.8

31.33

23.53

mg/l

0.80

146

(40765089) Chromosome analysis panel - Blood by G-banded

0.00

1.34

0.0

1.0

—

(3009214) Lutropin [Units/volume] in Serum or Plasma

317

1.40

1.32

1.4

1.3

11.35

11.34

u/l

0.00

246

(4094501) Cardiovascular stress test using bicycle ergometer

294

0.61

1.30

1.0

1.1

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

2.10

1.30

1.6

1.3

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

161

1.56

1.29

1.4

1.3

—

(3002523) Influenza virus A Ag [Presence] in Specimen

211

1.48

1.26

1.1

—

(3003740) Influenza virus B Ag [Presence] in Specimen

211

1.48

1.26

1.1

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

1.77

1.23

2.1

1.2

—

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

155

1329

1.19

1.20

1.5

1.7

1.52

1.40

0.81

132

1178

(3010726) Horse dander IgE Ab [Units/volume] in Serum

213

0.56

1.20

1.2

1.1

1.06

1.34

u/ml

—

110

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

1.75

1.19

2.1

1.3

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

125

1.61

1.18

1.2

1.1

—

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

1138

11087

1.14

1.17

4.2

3.8

1.27

mmol/l

0.07

1069

10214

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

2.51

1.15

1.2

1.1

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

2.01

1.12

4.5

2.3

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

685

1.24

1.10

1.7

1.4

—

(3002331) Protein [Mass/volume] in Peritoneal fluid

2.39

1.09

1.6

1.3

38.20

25.71

g/l

—

(3035637) Corticotropin [Mass/volume] in Plasma

144

1.54

1.09

1.5

1.6

—

(3036071) Salmonella sp Ab [Titer] in Serum

1.96

1.09

1.4

1.1

—

(3036180) Methadone [Presence] in Urine

1.96

1.09

1.0

1.6

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

519

0.74

1.04

1.5

1.7

6.27

4.51

mg/l

0.35

377

(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum

1.88

1.00

2.1

800.46

19.72

ug/l

—

(3034274) Bile acid [Moles/volume] in Serum --fasting

172

1.46

1.00

2.3

2.5

5.54

5.56

umol/l

0.01

115

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

1.95

0.97

1.7

1.4

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

489

1.26

0.95

1.5

1.6

—

(3002079) Sodium [Moles/time] in 24 hour Urine

1.77

0.94

1.4

158.33

144.19

mmol/24h

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

154

1354

1.15

0.92

6.9

6.1

—

(3001893) Eosinophils/100 leukocytes in Pleural fluid

2.15

0.91

1.5

1.2

0.83

3.73

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

849

0.82

0.91

1.2

—

(40761511) CBC panel - Blood by Automated count

1250

12304

1.16

0.90

23.5

11.6

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

119

1.52

0.88

3.0

2.4

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

1.65

0.88

1.2

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

346

0.72

0.88

1.5

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

252

0.67

0.86

1.2

1.1

0.90

2.18

u/ml

—

135

(3002256) Pathology report gross observation

165

1466

1.14

0.86

1.3

—

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

145

1.46

0.85

1.3

1.5

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

1.94

0.84

1.0

1.1

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

122

1392

0.86

0.81

1.8

—

(3041354) Potassium [Moles/volume] in Venous blood

122

1.48

0.80

3.0

2.4

3.89

3.98

mmol/l

0.34

122

(3035285) Chloride [Moles/volume] in Venous blood

122

1.48

0.80

3.0

2.4

105.94

105.71

mmol/l

0.04

122

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

1172

11508

1.12

0.79

4.7

4.2

1.50

1.53

mmol/l

1.53

1106

10680

(3016628) Fibrinogen Ag [Mass/volume] in Platelet poor plasma by Immunoassay

0.00

0.79

0.0

1.2

—

185.07

—

(40760548) Muscle specific receptor tyrosine kinase Ab [Units/volume] in Serum by Immunoassay

0.00

0.79

0.0

1.1

—

(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma

376

1.26

0.78

1.5

1.4

157.87

188.75

pmol/l

0.19

369

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

1196

11761

1.12

0.77

5.0

4.7

2.58

2.83

mmol/l

21.94

1126

10909

(3009542) Hematocrit [Volume Fraction] of Blood

1322

13094

1.19

0.72

43.3

18.3

38.74

39.81

8.50

1259

12355

(40761539) Cells [Type] in Urine sediment by Light microscopy

1.85

0.68

1.6

1.1

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

753

1.17

0.68

1.4

36.54

29.04

iu/l

1.04

635

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

1151

11314

1.10

0.68

4.7

4.3

5.58

5.84

mmol/l

10.83

1079

10352

(3023511) Choriogonadotropin [Units/volume] in Urine

329

0.76

0.68

1.2

—

(3033799) Differential panel - Peritoneal fluid

1.79

0.66

1.8

1.9

—

(3007461) Platelets [#/volume] in Blood

1322

13103

1.18

0.65

43.4

18.3

252.40

259.22

e9/l

2.93

1310

12791

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

161

1458

1.12

0.65

3.8

4.6

1.67

2.22

ug/l

1.20

140

1297

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

1175

11568

1.10

0.64

4.7

4.2

4.51

4.79

mmol/l

19.07

1113

10788

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

302

0.76

0.62

1.7

—

(3024731) MCV [Entitic volume]

1322

13107

1.17

0.62

43.2

18.2

91.40

90.78

4.78

1316

12937

(3008401) Mugwort IgE Ab [Units/volume] in Serum

210

0.71

0.61

1.1

0.13

1.41

u/ml

—

(4034850) Laboratory test

389

0.79

0.60

28.0

8.6

—

(3035941) MCH [Entitic mass]

1322

13110

1.17

0.60

43.1

18.2

30.22

30.18

0.29

1316

12939

(3026361) Erythrocytes [#/volume] in Blood

1322

13110

1.17

0.60

43.4

18.3

4.32

4.46

e12/l

23.58

1306

12763

(3010813) Leukocytes [#/volume] in Blood

1322

13111

1.17

0.59

43.4

18.3

6.38

6.59

e9/l

2.73

1308

12764

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

1.54

0.59

3.5

3.1

—

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

1.48

0.57

1.0

1.1

—

(3000963) Hemoglobin [Mass/volume] in Blood

1322

13116

1.16

0.56

43.6

18.4

129.44

133.90

g/l

28.00

1315

12943

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

739

1.15

0.55

1.8

1.7

—

(3019832) Treponema pallidum Ab [Presence] in Serum

144

1312

1.11

0.54

1.6

—

(3008295) Osmolality of Serum or Plasma

116

1.38

0.54

1.1

1.6

269.36

279.28

mosm/kgh2o

0.93

(3035933) Granulocytes/100 leukocytes in Blood

1.58

0.54

1.3

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

283

2663

1.08

0.53

1.7

1.4

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

554

1.14

0.44

1.7

2.1

8844.63

4593.95

u/l

0.30

230

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

437

0.84

0.44

1.9

1.8

—

(3003888) Timothy IgE Ab [Units/volume] in Serum

219

0.77

0.44

1.2

1.1

7.29

4.46

u/ml

—

113

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

195

0.77

0.41

1.3

1.7

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

1.52

0.41

2.4

3.1

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

1.52

0.41

2.4

3.1

—

(3011288) Drugs identified in Urine by Screen method

293

0.82

0.40

2.0

1.7

—

(3019420) Tryptase [Mass/volume] in Serum or Plasma

1.40

0.40

1.1

1.7

4.48

7.84

ug/l

1.27

(3043410) Blood group antigens tested for on Red Blood Cells

1.43

0.39

2.0

1.3

—

(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright

1.43

0.39

1.4

1.2

481.40

317.41

pmol/l

—

(4281824) Cell count and differential, peritoneal fluid

147

0.75

0.37

1.5

1.1

—

(3021387) Prolactin [Units/volume] in Serum or Plasma

487

1.13

0.37

1.4

1.6

221.16

311.16

mu/l

3.60

436

(3017446) Testosterone [Moles/volume] in Serum or Plasma

441

1.14

0.36

2.6

2.0

11.33

11.59

nmol/l

0.07

397

(3020191) Ethanol [Moles/volume] in Serum or Plasma

0.64

0.35

1.0

1.6

0.82

1.21

promille

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

217

1.20

0.35

1.3

1.5

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

1.37

0.34

1.0

1.2

116.78

149.13

pmol/l

—

(3004451) EKG impression Narrative

1.33

0.33

1.5

1.3

—

(40768800) Prostate Pathology biopsy report

0.70

0.33

1.2

1.1

—

(3016879) Cocaine [Presence] in Urine

412

0.87

0.32

1.5

—

(3027008) Opiates [Presence] in Urine

442

0.88

0.30

1.5

—

(3027944) Amphetamines [Presence] in Urine

436

0.89

0.26

1.5

—

(3020891) Body temperature

396

1.11

0.25

3.6

4.2

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

1.23

0.25

1.3

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

1.20

0.25

1.2

1.8

—

(3028300) Cannabinoids [Presence] in Urine

444

0.90

0.24

1.5

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

1.27

0.24

1.1

1.3

—

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

1.17

0.24

1.1

1.4

1.62

1.60

g/l

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

165

1576

1.05

0.24

1.7

2.1

—

(3041806) Other cells [#/volume] in Blood by Manual count

1.32

0.23

1.2

1.6

—

(44813793) Dust mix specific IgE antibody measurement

1.25

0.22

1.0

1.1

—

(3000764) Benzodiazepines [Presence] in Urine

441

0.90

0.22

1.5

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

555

0.92

0.22

1.5

1.4

—

(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture

0.00

0.21

0.0

1.2

—

(3008402) Methanol [Moles/volume] in Serum or Plasma

0.00

0.21

0.0

1.5

—

(3015616) Isopropanol [Moles/volume] in Serum or Plasma

0.00

0.21

0.0

1.7

—

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

0.00

0.21

0.0

7.1

—

(3018851) Theophylline [Moles/volume] in Serum or Plasma

0.00

0.21

0.0

2.3

—

50.25

—

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

0.00

0.20

0.0

1.3

—

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

0.00

0.20

0.0

1.3

—

(3003694) ABO and Rh group [Type] in Blood

339

3305

1.03

0.20

1.5

—

(4146454) Self-monitoring of blood glucose

1.21

0.19

4.1

2.7

—

(3005570) Glucose [Moles/volume] in Urine

118

1.19

0.19

2.3

2.0

—

(3017315) Amylase [Enzymatic activity/volume] in Urine

1.13

0.18

1.0

1.2

436.00

429.23

u/l

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

213

1.13

0.18

1.3

1.2

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

248

0.89

0.18

1.2

1.5

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

1.17

0.17

1.1

1.5

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

0.76

0.17

1.4

1.3

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

340

0.91

0.17

1.6

1.4

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

0.79

0.15

4.0

6.3

—

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

419

1.08

0.15

1.4

1.7

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

953

1.04

0.12

1.8

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

158

0.88

0.12

1.1

1.2

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

157

0.89

0.11

1.1

—

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

238

0.92

0.09

1.9

0.92

0.84

nmol/l

0.18

195

(3028707) Methadone [Presence] in Urine by Screen method

203

1.09

0.09

1.6

1.5

—

(3015183) Erythrocyte sedimentation rate

0.82

0.07

1.2

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

856

1.03

0.07

2.5

2.8

0.75

0.73

ug/l

0.06

544

(1617658) Protocol used for examination of sentinel lymph nodes

137

1.10

0.07

1.1

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

560

1.04

0.07

1.7

1.4

—

(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma

1.11

0.05

1.2

1.5

0.96

g/l

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

119

1171

1.02

0.05

3.1

4.0

21.66

21.63

0.01

531

(40768793) Breast Pathology biopsy report

382

0.97

0.04

1.3

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

143

1414

1.01

0.03

1.7

2.0

—

(3006270) Folate [Moles/volume] in Blood

1.09

0.03

1.4

1.2

351.07

408.93

nmol/l

—

(3039443) Prostate specific Ag panel - Serum or Plasma

107

0.93

0.02

1.2

1.5

—

(1002224) Polysomnography panel

513

1.01

0.01

1.1

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

133

1336

1.00

0.00

1.5

1.4

—

(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma

272

0.99

0.00

3.5

3.6

28.30

30.53

u/ml

0.08

265

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

349

1.00

0.00

2.1

2.0

9.26

5.05

iu/l

0.58

124

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

0.88

-0.00

1.5

1.3

—

(3011325) HIV 1+2 Ab [Presence] in Serum

0.00

-0.00

0.0

1.0

—

(40760410) HLA-B [Type] by High resolution

0.00

-0.00

0.0

1.0

—

(40765091) Chromosome analysis panel - Chorionic villus sample by G-banded

0.00

-0.00

0.0

1.0

—

(40761995) Spermatozoa Progressive [#/volume] in Semen

0.00

-0.00

0.0

3.1

—

(3023530) 17-Hydroxyprogesterone [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

1.0

—

1.91

—

(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum

0.00

-0.00

0.0

1.0

—

(3018081) Beta-2-Microglobulin [Mass/volume] in Urine

0.00

-0.00

0.0

1.8

—

9.35

—

(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum

0.00

-0.00

0.0

2.0

—

(3033093) Yersinia sp IgM Ab [Titer] in Serum

0.00

-0.00

0.0

2.0

—

(40763590) HLA-DQ beta [Type]

0.00

-0.00

0.0

1.0

—

(3025886) Oxalate [Mass/time] in 24 hour Urine

0.00

-0.00

0.0

1.0

—

(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen

0.00

-0.00

0.0

6.3

—

(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum

0.00

-0.00

0.0

2.0

—

(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen

0.00

-0.00

0.0

1.0

—

(40763476) Honey bee phospholipase A2 recombinant (rApi m) 1 IgE Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

(46236302) HLA-C [Type] by High resolution typing

0.00

-0.00

0.0

1.0

—

(3043681) Transitional cells [#/area] in Urine by Computer assisted method

0.00

-0.00

0.0

1.2

—

1.00

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

0.98

-0.00

1.1

—

(40760409) HLA-A [Type] by High resolution

0.00

-0.00

0.0

1.0

—

(3006653) Thiamine [Moles/volume] in Blood

1.00

-0.00

1.2

1.6

115.17

141.39

nmol/l

—

(3027570) Oxalate [Moles/time] in 24 hour Urine

0.00

-0.00

0.0

1.6

—

323.25

—

(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method

0.00

-0.00

0.0

1.0

—

(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma

0.00

-0.00

0.0

1.7

—

(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination

0.00

-0.00

0.0

1.0

—

(40763480) Human metapneumovirus Ag [Presence] in Specimen

0.00

-0.00

0.0

1.0

—

(3023436) Glucagon [Mass/volume] in Serum or Plasma

0.00

-0.00

0.0

2.0

—

181.86

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

0.89

-0.00

1.2

1.1

—

(3012984) Norclozapine [Mass/volume] in Serum or Plasma

0.00

-0.00

0.0

8.1

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

0.89

-0.00

1.0

1.2

—

(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination

0.00

-0.00

0.0

1.0

—

Mortality – FinRegistry

↥

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

Relationships between endpoints

↥

Index endpoint: M13_SLE – Systemic lupus erythematosus

GWS hits: -

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

≡ Risteys

R13

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Systemic lupus erythematosus

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

All original rules

Similar endpoints

Case counts by codes

Upset plot

Case counts by code for Systemic lupus erythematosus (M13_SLE)

Summary Statistics

-FinRegistry-

-FinnGen-

Key figures

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Relationships between endpoints